COMBINAÇÕES DE MISTURA PARA PROTEÇÃO DE CULTURAS
Combining Tau-fluvalinate with diverse crop protection chemicals creates synergistic mixtures that enhance pest control, broaden activity, and manage resistance, addressing the limitations of single-agent use.
Patent Information
- Application Number
- BR112025024310
- Authority / Receiving Office
- BR · BR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-08
- Filing Date
- 2024-05-08
- Publication Date
- 2026-11-10
AI Technical Summary
Existing crop protection chemicals often lead to pest resistance and inadequate pest control, necessitating the development of synergistic mixtures that provide broad-spectrum activity, prolonged control, and resistance management with reduced dosing rates.
Combining Tau-fluvalinate with various crop protection chemicals, including synthetic pyrethroids, fungicides, and insect growth regulators, to achieve synergistic pest control and resistance management.
The mixture combinations exhibit enhanced pest control, broad-spectrum activity, and prolonged effectiveness while reducing the need for higher dosages, thus managing resistance and lowering treatment costs.
Abstract
Description
1 / 156 MIXTURE COMBINATIONS FOR CROP PROTECTION
[0001] This application claims benefits from U.S. Provisional Application Number 63 / 464,640, filed May 8, 2023; the entire contents of which are incorporated herein by reference.
[0002] Throughout this application, several publications are cited. Disclosures of the documents and publications referred to herein are hereby incorporated in their entirety by reference in this application. AREA OF THE INVENTION
[0003] The present invention relates to combinations of mixtures of active compounds comprising Taufluvalinate and at least one additional crop protection chemical and to methods for controlling pests comprising applying said combinations. BACKGROUND OF THE INVENTION
[0004] The vulnerability of crops to unwanted pests and fungi makes crop protection management one of the main components of the total agricultural production system. Various insects and fungi, together with unwanted weeds, are very harmful to crop plants and can significantly reduce yields and crop quality. Insecticides, alone or in combination with fungicides and herbicides, help to minimize this damage by controlling crop threats. Many crop protection chemicals, both from the same class and mixtures of different classes, are commercially available for these purposes.
[0005] Combinations of insecticides or mixtures of one or more insecticides with other crop protection chemicals Petition 870250102105, dated 07 / 11 / 2025, page 23 / 195 2 / 156 are typically used to broaden the spectrum of control, to minimize the doses of chemicals used, to delay the development of resistance, and to reduce the cost of treatment through an additive effect. Although many combinations of an insecticidal agent with one or more crop protection chemicals have been studied, a synergistic effect is rarely achieved.
[0006] Practical agricultural experience has shown that the repeated and exclusive application of a single active compound in the control of insect pests often leads to the selection of those pests that have developed natural or adapted resistance to the active compound in question. Effective control of these pests with the active compound in question is then no longer possible.
[0007] Another difficulty regarding the use of insecticides is that the repeated and exclusive application of a single insecticidal compound often leads to a rapid selection of pests that have developed natural or adapted resistance to the active compound in question. Therefore, there is a need for crop protection chemicals that help prevent or overcome resistance. In order to reduce the risk of insect pests becoming resistant to certain active compounds, mixtures of different crop protection chemicals are now conventionally used to control insect pests. By combining carefully selected active compounds with different mechanisms of action, it is possible to ensure successful control over a relatively long period of time. Petition 870250102105, dated 07 / 11 / 2025, page 24 / 195 3 / 156
[0008] Tau-fluvalinato, (N-(2-Chloro-a,a,α-trifluoro-ptolyl)-D-valinato de (RS)-a-cyano-3-phenoxybenzyl), It is described in The E-Pesticide Manual (Version 5.0.1, 2010, 15th Edition, Publisher: CDS Tomlin) Entry number 423, and is an acaricide (e.g., miticide) that is commonly used to control Varroa mites in honeybee colonies, infestations of which constitute a significant disease of such insects.
[0009] Mixtures of active agents are described in the literature. However, pest control does not always meet the needs of agricultural practice. Additionally, the effectiveness of mixtures is not entirely satisfactory in cases of pest control and / or toxicological and / or environmental effects. Random pesticide compositions and mixtures do not exert a satisfactory control effect in most cases and, therefore, there is an urgent need for the development of new pesticide mixtures with a more crop protection chemical having some satisfactory control effects.
[0010] It is an object of the present invention to provide mixtures and compositions of carefully selected crop protection chemicals which, when applied in a reduced total amount of active compounds, have Petition 870250102105, dated 07 / 11 / 2025, page 25 / 195 4 / 156 Improved activity against harmful pests. It is an object of the present invention to provide an expanded spectrum of activity or a combination of inactivation activity with prolonged control. It is a further object of the present invention to provide mixtures and compositions that provide effective resistance management and control of insect pests at application rates that are as low as possible.
[0011] It is an effort of the present invention to discover that mixtures comprising Tau fluvalinate and at least one additional crop protection chemical are synergistically effective when applied simultaneously, i.e., together or separately, or in succession, allowing better control of insect pests than is possible with the individual compounds alone, providing synergistic results and solving at least one of the challenges of the prior art by reducing the dosing rate or intensifying the spectrum of activity or combining inactivation activity with prolonged control or facilitating resistance management.
[0012] In light of the above, the present invention strives for an effective blending combination of crop protection chemicals that exhibit synergistically enhanced action, a broader scope of activity, and reduced treatment cost. SUMMARY OF THE PRESENT INVENTION
[0013] We have reasonably found that the objective as described above is achieved in whole or in part by the combination of active compounds defined below. Petition 870250102105, dated 07 / 11 / 2025, page 26 / 195 5 / 156
[0014] The present invention relates to a mixture combination comprising, as active compounds: i) Tau-fluvalinate; and ii) at least one crop protection chemical compound II selected from groups (1) to (37): (1) a synthetic pyrethroid selected from a group consisting of Gamma-cyhalothrin, Alpha-cypermethrin, Etofenprox and Tefluthrin, (2) a competitive modulator of the nicotinic acetylcholine receptor (nAChR) selected from a group comprising Flupiradifurone, Flupirimine and Triflumezopirim, (3) an uncoupler of oxidative phosphorylation through proton gradient disruption comprising Chlorfenapyr and Brochlorfenapyr, (4) a ryanodine receptor modulator selected from a group comprising Tetrachlorantraniliprole and Thiotraniliprole, (5) a nicotinic acetylcholine receptor channel blocker selected from a group comprising Bensultape, Cartap hydrochloride, Thiocyclam and Tissultapesodium, (6) a mitochondrial electron transport inhibitor (METI) selected from a group comprising Fenazaquin, Pyridaben, Pirimidifen, Tebufenpyrad and Cietpirafen, (7) a meta-diamide insecticide selected from a group comprising Fluxamethamide and Isocycloseram,(8) a broad-spectrum insect growth regulator selected from a group comprising Fenoxicarb, Petition 870250102105, dated 07 / 11 / 2025, page 27 / 195 6 / 156 (9) an allosteric modulator of the glutamate-gated chloride channel (GluCl) selected from a group comprising Milbemectin and Lepimectin, (10) a voltage-dependent sodium channel blocker selected from a group comprising Metaflumizone, (11) a chitin biosynthesis inhibitor affecting CHS1, selected from a group comprising Diflubenzurone, Flufenoxurone, Lufenurone, Teflubenzurone and Chlorfluazurone, (12) an acetyl CoA carboxylase inhibitor selected from a group comprising Spidoxamate, Spirodiclofen and Spiromesifen, (13) an entomopathogenic fungal agent comprising Beauveria spp., Metarhizium spp. and Paecilomyces spp., (14) a baculovirus comprising: Granuloviruses such as GV of Cydia pomonella, GV of Thaumatotibia leucotreta, - Nucleopolyhedrosis viruses such as MNPV of Anticarsia gemmatalis and MNPV of Helicoverpa armigera, (15) An inhibitor of mitochondrial complex III electron transport - Qi site comprising Flomethoquine, (16) an inhibitor of chitin biosynthesis (type 1) comprising Buprofezin, (17) an ecdysone receptor agonist comprising Cromafenozide, Halofenozide, Methoxyfenozide and Tebufenozide, (18) An inhibitor of mitochondrial complex III electron transport (QO site) comprising Acequinocil, Fluacripyrim and Hydramethylnon, (19) A cyclotide insecticide and repellent comprising Clitoria ternatea, Petition 870250102105, dated 07 / 11 / 2025, page 28 / 195 7 / 156 (20) an allosteric modulator of the nicotinic acetylcholine receptor (nAChR) (site II) comprising GSomega peptide / kappa HXTX-Hv1a, (21) a modulator of the calcium-activated potassium channel (KCa2) comprising acinonapyr, (22) a synergistic insecticidal agent comprising N-octyl bicycloheptene dicarboximide (MGK-264), Piprotal, Propyl isosome, Sesamex, Sesamolin and Sulfoxide, (23) a fungicide selected from a group comprising Pidiflumethophene, Fluazinam, Fluxapyroxad, Difenoconazole, Tebuconazole, Fludioxonil, Azoxystrobin and Mancozeb, (24) a neonicotinoid insecticide selected from a group comprising Cycloxapride, Guadipyr and Imidaclotiz, (25) an acaricide selected from a group comprising cyflumethophene and sila-cyflumethophene, (26) a diamide insecticide selected from a group comprising cyproflanilide, (27) a mesoionic insecticide selected from a group comprising dichloromezotiaz and phenmezodithiaz,(28) a pyrazole carboxamide insecticide selected from a group comprising dimpropyridaz, ticlopyrazoflor, fluchlordiniliprole, (29) a sulfonamide nematicide selected from a group comprising fluazaindolizine, (30) a phenylpyrazole insecticide selected from a group comprising flufiprol, nicofluprol and piriprol, (31) a fluorine-containing insecticide selected from a group comprising fluhexaphone, bistriflurone and trifluenfuronate, Petition 870250102105, dated 07 / 11 / 2025, page 29 / 195 8 / 156 (32) an isoxazoline parasiticide selected from a group comprising lotilaner, (33) an indazole insecticide selected from a group comprising indazapyroxamet, (34) one or more mineral oils including paraffinic oils, (35) a plant extract selected from a group comprising garlic extract, bitterberry extract, tea tree oil, clove oil, (36) a monoterpene alcohol extracted from essential oils selected from a group comprising citronella oil, rose oil and palmarosa oil, (37) a repellent selected from a group comprising thymol and citronella; and (38) one or more agrochemically acceptable additives selected from a group comprising Diatomaceous earth, Amorphous silica, Hydroxypropylmethylcellulose, Kaolin (calcined), Polydimethylsiloxane and Potassium salts of fatty acids.
[0015] The present invention further specifically provides a mixture combination comprising Taufluvalinate and at least one crop protection chemical selected from a group comprising Gamma-cyhalothrin, Alpha-cypermethrin, Etofenprox, Tefluthrin, Flupiradifurone, Flupirimine, Triflumezopyrim, Chlorfenapyr, Brochlorfenapyr, Tetrachlorantraniliprole, Thiotraniliprole, Bensultap, Cartap hydrochloride, Thiocyclam, Tissultap sodium, Phenazaquine, Pyridaben, Pirimidifen, Tebufenpyrad, Cietpirafene, Fluxamethamide, Isocycloseram, Fenoxicarb, Milbemectin, Lepimectin, Metaflumizone, Diflubenzuron, Petition 870250102105, dated 07 / 11 / 2025, page 30 / 195 9 / 156 Flufenoxurone, Lufenurone, Teflubenzurone, Chlorfluazurone, Spidoxamate, Spirodiclofen, Spiromesifen, Beauveria spp., Metarhizium spp., Paecilomyces spp., GV of Cydia pomonella, GV of Thaumatotibia leucotreta, MNPV of Anticarsia gemmatalis, NPV of Helicoverpa armigera, Flomethoquine, Buprofezin, Chromafenozide, Halofenozide, Methoxyfenozide, Tebufenozide, Acequinocil, Fluacripyrim, Hydramethylnon, Clitoria ternatea, GS-omega / kappa HXTX-Hv1a peptide, Acinonapyr, N-octyl bicycloheptene dicarboximide (MGK-264), Piprotal, Propyl isosome, Sesamex, Sesamolin and Sulfoxide, Pidiflumetofen, Fluazinam, Fluxapyroxad, Difenoconazole, Tebuconazole, Fludioxonil, Azoxystrobin, Mancozeb, Cycloxapride, Guadipir, Imidaclotiz, Ciflumetofen, Sila-Ciflumetofen, Ciproflanilide, Dichloromezothiaz, Fenmezodithiaz, Dimpropyridaz, Ticlopyrazoflor, Fluchlordiniliprol, Fluazaindolizine, Flufiprol, Nicofluprol, Piriprol, Fluhexaphone, Bistriflurone, Trifluenfuronate, Lotilaner, Indazapyroxamet, Mineral oil, Garlic extract, Bitter melon extract, Tea tree oil, Clove oil, Citronella oil, Rose oil, Palmarosa oil, Thymol, Citronella and also agrochemically acceptable additives.
[0016] Furthermore, it is discovered in the present invention that the simultaneous application, i.e., together or separately, of Tau-fluvalinate and one or more active compounds II or the successive application of compound I and one or more active compounds II, as mentioned above, allows intensified pest control compared with the control rates that are possible with the individual compounds. Petition 870250102105, dated 07 / 11 / 2025, page 31 / 195 10 / 156
[0017] The present invention provides a mixture combination wherein the weight ratio of Tau-fluvalinate and one or more active compounds II, as mentioned above, is from 1:100 to 100:1, and the amount of each active ingredient is about 0.1-99% by weight, about 0.1-95% by weight, or about 0.190% by weight, based on the total weight of the mixture composition.
[0018] The present invention provides a mixture combination comprising Tau-fluvalinate and one or more active compounds II, as mentioned above, wherein the application rates of the mixture according to the invention are from 1 g / ha to 1000 g / ha.
[0019] The present invention further provides a mixture combination comprising a mixture of Taufluvalinate and one or more active compounds II, as mentioned above, comprising an agriculturally acceptable carrier and further comprising at least one surfactant, solid diluent, liquid diluent or a combination thereof.
[0020] This present invention also provides a method for controlling insects comprising contacting the insect or its food supply, habitat, breeding areas or locus with an effective amount of the mixture of Tau-fluvalinate and one or more active compounds II, as mentioned above or the composition thereof, so as to control the insects in this way.
[0021] The present invention further provides a method for protecting plants from insect attack or infestation comprising contacting the plant, or the soil or water in which the plant is growing, with an effective amount of the mixture of Tau-fluvalinate and one or more active compounds. Petition 870250102105, dated 07 / 11 / 2025, page 32 / 195 11 / 156 II, as mentioned above, or their composition, in order to protect the plants from insect attack or infestation.
[0022] This present invention also provides a method for enhancing the inactivation and / or prolonged control activity comprising contacting the plant, or the soil or water in which the plant is growing, with an effective amount of the mixture of Tau-fluvalinate and one or more active compounds II, as mentioned above, or a combination thereof, so as to thereby enhance the inactivation and / or prolonged control activity.
[0023] This present invention further provides a method for enhancing plant development comprising applying to the plant, a plant locus and / or plant propagation material an effective amount of the mixture of Tau-fluvalinate and one or more active compounds II, as mentioned above, or a composition thereof, so as to thereby enhance plant development.
[0024] Furthermore, this present invention provides a method for regulating plant growth comprising applying to the plant, to a plant locus and / or plant propagation material an effective amount of Taufluvalinate and one or more active compounds II, as mentioned above, or a combination thereof, so as to regulate plant growth in this manner. DETAILED DESCRIPTION OF THE PRESENT INVENTION Definitions
[0025] Before presenting the present subject in detail, it may be useful to provide definitions of certain terms to be used herein. Unless otherwise defined, Petition 870250102105, dated 07 / 11 / 2025, p. 33 / 195 12 / 156 All technical and scientific terms used herein have the same meaning as is commonly understood by an expert in the technique to which this subject pertains.
[0026] As used herein, the term “crop protection chemical” is intended to include, but is not limited to, a herbicide, an insecticide, a fungicide, an insect growth regulator, and a microbial disruptor. Insect growth regulators (IGRs) are substances that disrupt and / or inhibit the life cycle of insect pests. IGRs include juvenile hormone mimetics, ecdysone agonists, and chitin synthesis inhibitors. As an insect grows, it molts, developing a new exoskeleton under its old one and then shedding the old one to allow the new one to swell to a new size and harden. IGRs prevent an insect from reaching maturity by interfering with the molting process.
[0027] As used herein, the term “pests” is used to include animal pests as well as harmful fungi.
[0028] As used herein, the term “AI” refers to the active ingredient.
[0029] As used herein, the terms “control” or “control” are intended to include, but not be limited to, any killing, growth regulation, inhibition, or interference with the normal life cycle activities of a given pest. These terms include, for example, preventing larvae from developing into mature insects, modulating the emergence of pests from eggs including preventing hatching, degrading egg material, suffocation, reducing intestinal motility, inhibiting chitin formation, disrupting mating or sexual communication. Petition 870250102105, dated 07 / 11 / 2025, p. 34 / 195 13 / 156 and prevent feeding activity. The terms control and control also include the ability to modulate or inhibit the growth or proliferation or colony formation of an organism or a population of organisms.
[0030] As used herein, the term inactivation activity or inactivation treatment means an application of one or more insecticides to control insect infestation of the plant or locus before and / or after an infestation or before and / or after insect damage is shown and / or when pest pressure is low / high. Insect pressure can be assessed based on conditions associated with insect development such as population density and certain environmental conditions.
[0031] As used herein, the term prolonged control means obtaining insecticidal activity over a prolonged period after the application of one or more insecticides to control insect infestation of the plant or locus over a long period of time, before and / or after an infestation or before and / or after insect damage is shown and / or when insect pressure is low / high. Insect pressure can be assessed based on conditions associated with insect development such as population density and certain environmental conditions.
[0032] As used herein, the term effective when used to describe a method for controlling unwanted pests, such as nematodes, means that the method provides a good level of control of the unwanted pest without significantly interfering with the normal growth and development of the crop. Petition 870250102105, dated 07 / 11 / 2025, page 35 / 195 14 / 156
[0033] As used herein, the term “effective amount” when used in connection with an active ingredient refers to an amount of the active ingredient which, when ingested, contacted or detected, is sufficient to achieve a good level of control or activity.
[0034] As used herein, the term “effective amount” when used in connection with a non-active component, i.e., additive, such as a polymer and organic carrier, refers to an amount of the additive that is sufficient to improve the stability of the composition.
[0035] As used herein, the term “agriculturally acceptable carrier” means a carrier that is known and accepted in the art for forming compositions for agricultural or horticultural use.
[0036] As used herein, the term “adjuvant” is broadly defined as any substance that is not itself an active ingredient, but which enhances or is intended to enhance the effectiveness of the pesticide with which it is used. Adjuvants should be understood to include, but not be limited to, disseminating agents, penetrants, compatibility agents and drift retarders.
[0037] As used herein, the term “agriculturally acceptable additives” is defined as any substance that is not itself an active ingredient but is added to the composition such as thickening agents, adhesives, surfactants, antioxidants, antifoaming agents and thickeners.
[0038] As used herein, the term “tank mixing” means that two or more pesticides or chemical compositions are mixed in the spray tank at the time of application by spraying. Petition 870250102105, dated 07 / 11 / 2025, p. 36 / 195 15 / 156
[0039] As used herein, the term “ready-mixture” means a composition that can be applied to plants directly after dilution. The composition comprises the combination of the active ingredients. The term “mixture” or “combination” refers to, but is not limited to, a combination in any physical form, e.g., blend, solution, alloy, or the like.
[0040] As used herein, the term “plant” or “crop” includes reference to whole plants, plant organs (e.g., leaves, stems, branches, roots, trunks, twigs, shoots, fruits, etc.), plant cells, or plant seeds. This term also encompasses plant crops such as fruits. The term “plant” may also include its propagation material, which may include all generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers, which may be used for plant propagation. It may also include spores, shoots, bulbs, rhizomes, basal buds, stolons, and buds, and other plant parts, including seedlings and young plants, which must be transplanted after germination or after emergence from the soil.
[0041] As used herein, the term “locus” includes a habitat, breeding area, plant, propagation material, soil, area, material, or environment in which a pest is growing or may grow.
[0042] As used herein, the term “cultivated plants” includes plants that have been modified by breeding, mutagenesis, or genetic manipulation. Genetically modified plants are plants whose genetic material has been modified by the use of recombinant DNA techniques. Petition 870250102105, dated 07 / 11 / 2025, page 37 / 195 16 / 156 Typically, one or more genes have been integrated into the genetic material of such a plant in order to improve certain properties of the plant.
[0043] The term “plant health” encompasses various types of plant improvements that are not connected to pest control. For example, advantageous properties that can be mentioned are improved crop characteristics, including: emergence, crop yields, protein content, oil content, starch content, more developed root system (improved root growth), improved stress tolerance (e.g., against drought, heat, salt, UV, water, cold), reduced ethylene (reduced production and / or inhibition of reception), increased plant height, larger leaf blade, fewer dead basal leaves, stronger tillers, greener leaf color, pigment content, photosynthetic activity, lower input required (such as fertilizers or water), fewer seeds needed, more productive tillers, earlier flowering, earlier grain maturity, less plant inclination (lodging), increased shoot growth, increased plant vigor, increased ability of the plant to stand upright and earlier and better germination; or any other advantages familiar to a person skilled in the art.
[0044] The term “a” or “an” as used herein includes both the singular and the plural, unless specifically indicated otherwise. Therefore, the terms “a”, “an” or “at least one” may be used interchangeably in this application.
[0045] Throughout the application, descriptions of various modalities use the term “comprising”; however, it will be understood by a person skilled in the art that, in some cases Petition 870250102105, dated 07 / 11 / 2025, p. 38 / 195 17 / 156 specific, a modality may alternatively be described using the language “consisting essentially of” or “consisting of”.
[0046] As used herein, the term “locus” includes a habitat, breeding area, plant, propagation material, soil, area, material, or environment in which a pest is growing or may grow.
[0047] As used herein, the term “ha” refers to hectare.
[0048] As used herein, the term “g” refers to gram, and “L” or “l” refers to liter.
[0049] The term “ppm” is an abbreviation for “parts per million” and may also be expressed in milligrams per liter (mg / L). This measurement is the mass of a chemical or contaminant per unit volume of water or solvent in a formulation.
[0050] As used herein, the term “mixture” or “combination” refers to, but is not limited to, a combination in any physical form, e.g., blend, solution, suspension, dispersion, emulsion, alloy, or the like.
[0051] As used herein, the term “more effective” includes, but is not limited to, increasing the effectiveness of pesticide disease control, prolonging protection and reducing the amount of time required to achieve a given level of pesticide control, prolonging the duration of protection against pest attack after application, and extending the period of protection against pest attack and / or reducing the amount of time required to achieve a level of pest control compared to when each pesticide in the same quantity is applied alone.
[0052] The term “intensify crop plants” as used here means to improve one or more of the quality of Petition 870250102105, dated 07 / 11 / 2025, page 39 / 195 18 / 156 plants, plant vigor, nutrient uptake, root system, tolerance to stress factors and / or yield in a plant in which the mixture or composition described here was applied compared with a control plant grown under the same conditions except that the mixture or composition described here was not applied.
[0053] The term “strengthening the root system” as used herein means that the root system is improved qualitatively or quantitatively in a plant to which the mixture or composition described herein has been applied compared with the root systems in a control plant grown under the same conditions except that the mixture or composition described herein has not been applied. Strengthened root systems include but are not limited to improved visual appearance and composition of the root system (i.e., improved color, density and uniformity), increased root growth, a more developed root system, stronger and healthier roots, improved ability of the plant to stand upright and increased root system weight.
[0054] The term “improving plant quality” as used herein means that one or more traits are improved qualitatively or quantitatively in a plant to which the mixture or composition described herein has been applied compared with the same trait in a control plant grown under the same conditions except that the mixture or composition described herein has not been applied. Such traits include but are not limited to improved visual appearance and composition of the plant (i.e., improved color, density, uniformity, compactness), reduced ethylene Petition 870250102105, dated 07 / 11 / 2025, page 40 / 195 19 / 156 (reduced production and / or inhibition of reception), improved visual appearance and composition of the harvested material (i.e., seeds, fruits, leaves, vegetables, shoots / stems / canes), improved carbohydrate content (i.e., increased amounts of sugar and / or starch, improved sugar-acid ratio, reduction of reducing sugars, increased rate of sugar development), improved protein content, improved oil content and composition, improved nutritional value, reduction in antinutritional compounds, increased nutrient uptake, stronger and healthier roots, improved organoleptic properties (i.e., improved flavor), improved consumer health benefits (i.e., increased levels of vitamins and antioxidants), improved post-harvest characteristics (i.e., enhanced shelf life and / or storage stability, easier processing,easier extraction of compounds) and / or improved seed quality (i.e., for use in subsequent seasons).
[0055] As used herein, the term “regulating plant growth” or “regulating plant growth” includes restricting vertical stem growth, promoting root growth, stunting, increasing stem diameter and stem wall thickness, and the like.
[0056] As used herein, the term “plants” refers to any and all physical parts of a plant, including but not limited to seeds, seedlings, young plants, roots, tubers, stems, stalks, foliage and fruits. Petition 870250102105, dated 07 / 11 / 2025, p. 41 / 195 20 / 156
[0057] As used herein, the term surfactant means an agriculturally acceptable material that imparts emulsifiability, stability, spreading, wetting, dispersibility, or other surface-modifying properties. Examples of suitable surfactants include nonionic, anionic, cationic, and amphiphilic surfactants.
[0058] For the purposes of better understanding the present teachings and without in any way limiting the scope of the teachings, unless otherwise indicated, the numerical parameters presented in the following descriptive report and in the appended claims are approximations that may vary depending on the desired properties to be obtained. At a minimum, each numerical parameter should be interpreted in light of the reported number of significant digits and by applying common rounding techniques. In this respect, the use of the term approximately herein specifically includes ± 10% from the values indicated in the range. Additionally, the endpoints of all ranges directed to the same component or property herein include the endpoints, are independently combinable, and include all intermediate points and ranges.
[0059] Unless otherwise specified, references to percentages that are weight percentages of the active compounds in the composition of this invention are based on the total weight of the active ingredients in the composition, i.e., the active compounds themselves, excluding any amounts of solvents, carriers, dispersants, stabilizers or other materials that may be present. Petition 870250102105, dated 07 / 11 / 2025, page 42 / 195 21 / 156 [00 60] It is further understood that where a range of parameters is provided, all whole numbers within that range, and tenths thereof, are also provided by the subject. For example, “0.1% to 50%” includes 0.1%, 0.2%, 0.3%, 0.4%, etc., up to 50%. [00 61] When a ratio here must be “X:1 or higher”, it is understood that the ratio is Y:1, where Y is X or greater, and when a ratio here must be “X:1 or lower”, it is understood that the ratio is Z:1, where Z is X or less. The same logic follows for ratios that are “1:X or higher” and “1:X or lower”. Pesticide Mixtures
[0062] It has been surprisingly discovered that by combining Tau fluvalinate with one or more crop protection chemicals, mixture combinations are produced that exhibit a broad spectrum of control and high efficacy against a very wide range of insects, as well as having a long inactivation and residual effect under different climatic conditions. The mixtures and compositions of the present invention are based in part on the discovery that applying the mixture combination of the present invention to a locus or area where pest control is desired results in improved pest control and prevents further infestation.
[0063] In some embodiments, the combination provides a higher insecticidal activity than that predicted based on the sum of the activities of each of the insecticides found in it. Such a combination allows for reduced dosages of individual insecticides that can damage agriculturally important plants. Petition 870250102105, dated 07 / 11 / 2025, page 43 / 195 22 / 156
[0064] In one embodiment, the present invention relates to a mixture combination comprising, as active compounds: i) Tau-fluvalinate; and ii) at least one crop protection chemical compound II selected from groups (1) to (37): (1) a synthetic pyrethroid selected from a group consisting of Gamma-cyhalothrin, Alpha-cypermethrin, Etofenprox and Tefluthrin, (2) a competitive modulator of the nicotinic acetylcholine receptor (nAChR) selected from a group comprising Flupiradifurone, Flupirimine and Triflumezopirim, (3) an uncoupler of oxidative phosphorylation through proton gradient disruption comprising Chlorfenapyr and Brochlorfenapyr, (4) a ryanodine receptor modulator selected from a group comprising Tetrachlorantraniliprole and Thiotraniliprole, (5) a nicotinic acetylcholine receptor channel blocker selected from a group comprising Bensultape, Cartap hydrochloride, Thiocyclam and Tissultapesodium, (6) a mitochondrial electron transport inhibitor (METI) selected from a group comprising Fenazaquin, Pyridaben, Pirimidifen, Tebufenpyrad and Cietpirafen, (7) a meta-diamide insecticide selected from a group comprising Fluxamethamide and Isocycloseram,(8) a broad-spectrum insect growth regulator selected from a group comprising Fenoxicarb, Petition 870250102105, dated 07 / 11 / 2025, page 44 / 195 23 / 156 (9) an allosteric modulator of the glutamate-gated chloride channel (GluCl) selected from a group comprising Milbemectin and Lepimectin, (10) a voltage-dependent sodium channel blocker selected from a group comprising Metaflumizone, (11) a chitin biosynthesis inhibitor affecting CHS1, selected from a group comprising Diflubenzurone, Flufenoxurone, Lufenurone, Teflubenzurone and Chlorfluazurone, (12) an acetyl CoA carboxylase inhibitor selected from a group comprising Spidoxamate, Spirodiclofen and Spiromesifen, (13) an entomopathogenic fungal agent comprising Beauveria spp., Metarhizium spp. and Paecilomyces spp., (14) a baculovirus comprising: Granuloviruses such as GV of Cydia pomonella, GV of Thaumatotibia leucotreta, - Nucleopolyhedrosis viruses such as MNPV of Anticarsia gemmatalis and MNPV of Helicoverpa armigera, (15) An inhibitor of mitochondrial complex III electron transport - Qi site comprising Flomethoquine, (16) an inhibitor of chitin biosynthesis (type 1) comprising Buprofezin, (17) an ecdysone receptor agonist comprising Cromafenozide, Halofenozide, Methoxyfenozide and Tebufenozide, (18) An inhibitor of mitochondrial complex III electron transport (QO site) comprising Acequinocil, Fluacripyrim and Hydramethylnon, (19) A cyclotide insecticide and repellent comprising Clitoria ternatea, Petition 870250102105, dated 07 / 11 / 2025, page 45 / 195 24 / 156 (20) an allosteric modulator of the nicotinic acetylcholine receptor (nAChR) (site II) comprising GSomega peptide / kappa HXTX-Hv1a, (21) a modulator of the calcium-activated potassium channel (KCa2) comprising acinonapyr, (22) a synergistic insecticidal agent comprising N-octyl bicycloheptene dicarboximide (MGK-264), Piprotal, Propyl isosome, Sesamex, Sesamolin and Sulfoxide, (23) a fungicide selected from a group comprising Pidiflumethophene, Fluazinam, Fluxapyroxad, Difenoconazole, Tebuconazole, Fludioxonil, Azoxystrobin and Mancozeb, (24) a neonicotinoid insecticide selected from a group comprising Cycloxapride, Guadipyr and Imidaclotiz, (25) an acaricide selected from a group comprising cyflumethophene and sila-cyflumethophene, (26) a diamide insecticide selected from a group comprising cyproflanilide, (27) a mesoionic insecticide selected from a group comprising dichloromezotiaz and phenmezodithiaz,(28) a pyrazole carboxamide insecticide selected from a group comprising dimpropyridaz, ticlopyrazoflor, fluchlordiniliprole, (29) a sulfonamide nematicide selected from a group comprising fluazaindolizine, (30) a phenylpyrazole insecticide selected from a group comprising flufiprol, nicofluprol and piriprol, (31) a fluorine-containing insecticide selected from a group comprising fluhexaphone, bistriflurone and trifluenfuronate, Petition 870250102105, dated 07 / 11 / 2025, page 46 / 195 25 / 156 (32) an isoxazoline parasiticide selected from a group comprising lotilaner, (33) an indazole insecticide selected from a group comprising indazapyroxamet, (34) one or more mineral oils including paraffinic oils, (35) a plant extract selected from a group comprising garlic extract, bitterberry extract, tea tree oil, clove oil, (36) a monoterpene alcohol extracted from essential oils selected from a group comprising citronella oil, rose oil and palmarosa oil, (37) a repellent selected from a group comprising thymol and citronella; and (38) one or more agrochemically acceptable additives selected from a group comprising Diatomaceous earth, Amorphous silica, Hydroxypropylmethylcellulose, Kaolin (calcined), Polydimethylsiloxane and Potassium salts of fatty acids.
[0065] In one embodiment, crop protection chemical compound II is at least one of Gamma-cyhalothrin, Alpha-cypermethrin, Etofenprox and Tefluthrin.In one specific embodiment, the crop protection chemical compound II is Gamma-cyhalothrin. In another specific embodiment, the crop protection chemical compound II is Alpha-cypermethrin. In another specific embodiment, the crop protection chemical compound II is Etofenprox. In another specific embodiment, the crop protection chemical compound II is Tefluthrin. Petition 870250102105, dated 07 / 11 / 2025, page 47 / 195 26 / 156
[0066] In another embodiment, crop protection chemical compound II is at least one of Flupiradifurone, Flupirimine, and Triflumezopyrim. In a specific embodiment, crop protection chemical compound II is Flupiradifurone. In another specific embodiment, crop protection chemical compound II is Flupirimine. In another specific embodiment, crop protection chemical compound II is Triflumezopyrim.
[0067] In another embodiment, the crop protection chemical compound II is at least one of Chlorfenapyr and Brochlorfenapyr. In a specific embodiment, the crop protection chemical compound II is Chlorfenapyr. In another embodiment, the crop protection chemical compound II is Brochlorfenapyr.
[0068] In another embodiment, the crop protection chemical compound II is at least one of Tetrachloroantraniliprole and Thiotraniliprole. In a specific embodiment, the crop protection chemical compound II is Tetrachloroantraniliprole. In another embodiment, the crop protection chemical compound II is Thiotraniliprole.
[0069] In another embodiment, crop protection compound II is at least one of Bensultap, Cartap hydrochloride, Thiocyclam, and Tissultap-sodium. In a specific embodiment, crop protection chemical compound II is Bensultap. In another embodiment, crop protection chemical compound II is Cartap hydrochloride. In another embodiment, crop protection chemical compound II is Thiocyclam. In another embodiment, crop protection chemical compound II is Tissultap-sodium. Petition 870250102105, dated 07 / 11 / 2025, page 48 / 195 27 / 156
[0070] In another embodiment, crop protection compound II is at least one of Fenazaquin, Pyridaben, Pyrimidifen, Tebufenpyrad, and Cyetpyrafene. In a specific embodiment, crop protection compound II is Fenazaquin. In another embodiment, crop protection compound II is Pyridaben. In another embodiment, crop protection compound II is Pyrimidifen. In another embodiment, crop protection compound II is Tebufenpyrad. In another embodiment, crop protection compound II is Cyetpyrafene.
[0071] In another embodiment, the crop protection chemical compound II is at least one of Fluxamethamide and Isocycloseram. In a specific embodiment, the crop protection chemical compound II is Fluxamethamide. In another embodiment, the crop protection chemical compound II is Isocycloseram.
[0072] In an additional embodiment, the crop protection chemical compound II is Fenoxicarb.
[0073] In another embodiment, crop protection chemical compound II is at least one of Milbemectin and Lepimectin. In a specific embodiment, crop protection chemical compound II is Milbemectin. In another embodiment, crop protection chemical compound II is Lepimectin.
[0074] In an additional embodiment, the crop protection chemical compound II is Metaflumizone.
[0075] In another embodiment, crop protection compound II is at least one of Diflubenzurone, Flufenoxurone, Lufenurone, Teflubenzurone, and Chlorfluazurone. In a Petition 870250102105, dated 07 / 11 / 2025, page 49 / 195 28 / 156 specific embodiment, the crop protection chemical compound II is Diflubenzurone. In another embodiment, the crop protection chemical compound II is Flufenoxurone. In another embodiment, the crop protection chemical compound II is Flufenoxurone. In another embodiment, the crop protection chemical compound II is Teflubenzurone. In another embodiment, the crop protection chemical compound II is Chlorfluazurone.
[0076] In another embodiment, crop protection chemical compound II is at least one of Spidoxamate, Spirodiclofen, and Spiromesifen. In a specific embodiment, crop protection chemical compound II is Spidoxamate. In another embodiment, crop protection chemical compound II is Spirodiclofen. In another embodiment, crop protection chemical compound II is Spiromesifen.
[0077] In another embodiment, the crop protection chemical compound II is at least one of GV from Cydia pomonella and GV from Thaumatotibia leucotreta. In a specific embodiment, the crop protection chemical compound II is GV from Cydia pomonella. In another embodiment, the crop protection chemical compound II is GV from Thaumatotibia leucotreta.
[0078] In one embodiment, the crop protection chemical compound II is at least one of the MNPVs of Anticarsia gemmatalis and NPVs of Helicoverpa armigera. In a specific embodiment, the crop protection chemical compound II is MNPVs of Anticarsia gemmatalis. In another embodiment, the crop protection chemical compound II is NPVs of Helicoverpa armigera. Petition 870250102105, dated 07 / 11 / 2025, page 50 / 195 29 / 156
[0079] In an additional embodiment, crop protection chemical compound II is Flomethoquine.
[0080] In an additional embodiment, the crop protection chemical compound II is Buprofezin.
[0081] In another embodiment, crop protection compound II is at least one of Chromafenozide, Halofenozide, Methoxyfenozide, and Tebufenozide. In a specific embodiment, crop protection compound II is Chromafenozide. In another embodiment, crop protection compound II is Halofenozide. In another embodiment, crop protection compound II is Methoxyfenozide. In another embodiment, crop protection compound II is Tebufenozide.
[0082] In another embodiment, the crop protection chemical compound II is at least one of Acequinocil, Fluacripyrim, and Hydramethylnon. In a specific embodiment, the crop protection chemical compound II is Acequinocil. In another embodiment, the crop protection chemical compound II is Fluacripyrim. In another embodiment, the crop protection chemical compound II is Hydramethylnon.
[0083] In a further embodiment, the crop protection chemical compound II is Clitoria ternatea.
[0084] In a further embodiment, the crop protection chemical compound II is GS-omega peptide / HXTX-Hv1a.
[0085] In a further embodiment, the crop protection chemical compound II is Acinonapyr.
[0086] In one embodiment, crop protection chemical compound II is at least one of N-octyl bicycloheptene dicarboximide (MGK-264), Piprotal, Propyl isosome, Sesamex, Sesamolin, and Sulfoxide. In one embodiment Petition 870250102105, dated 07 / 11 / 2025, page 51 / 195 Specifically, chemical compound II for crop protection is N-octyl bicycloheptene dicarboximide (MGK-264). In another embodiment, chemical compound II for crop protection is Piprotal. In another embodiment, chemical compound II for crop protection is Propyl isome. In another embodiment, chemical compound II for crop protection is Sesamex. In another embodiment, chemical compound II for crop protection is Sesamolin. In another embodiment, chemical compound II for crop protection is Sulfoxide.
[0087] In another embodiment, crop protection compound II is at least one of the fungicides Pidiflumethophene, Fluazinam, Fluxapyroxad, Difenoconazole, Tebuconazole, Fludioxonil, Azoxystrobin, and Mancozeb. In a specific embodiment, crop protection compound II is Pidiflumethophene. In another embodiment, crop protection compound II is Fluazinam. In another specific embodiment, crop protection compound II is Fluxapyroxad. In another specific embodiment, crop protection compound II is Difenoconazole. In another specific embodiment, crop protection compound II is Tebuconazole. In another specific embodiment, crop protection compound II is Fludioxonil. In another specific embodiment, crop protection compound II is Azoxystrobin. In another specific embodiment, crop protection compound II is Mancozeb.
[0088] In another embodiment, crop protection chemical compound II is at least one of Cycloxapride, Guadipir, and Imidaclotz. In a specific embodiment, the Petition 870250102105, dated 07 / 11 / 2025, page 52 / 195 31 / 156 Crop protection chemical compound II is Cycloxapride. In another embodiment, crop protection chemical compound II is Guadipir. In yet another embodiment, crop protection chemical compound II is Imidaclotz.
[0089] In another embodiment, the crop protection chemical compound II is at least one of Cyflumethophene and SilaCyflumethophene. In a specific embodiment, the crop protection chemical compound II is Cyflumethophene. In another embodiment, the crop protection chemical compound II is Sila-Cyflumethophene.
[0090] In an additional embodiment, the crop protection chemical compound II is Ciproflanilide.
[0091] In another embodiment, crop protection chemical compound II is at least one of Dichloromezotiaz and Fenmezodithiaz. In a specific embodiment, crop protection chemical compound II is Dichloromezotiaz. In another embodiment, crop protection chemical compound II is Fenmezodithiaz.
[0092] In another embodiment, crop protection chemical compound II is at least one of Dimpropiridaz, Ticlopyrazoflor and Fluchlordiniliprol. In a specific embodiment, crop protection chemical compound II is Dimpropiridaz. In another embodiment, crop protection chemical compound II is Ticlopyrazoflor. In another embodiment, crop protection chemical compound II is Fluchlordiniliprol.
[0093] In an additional embodiment, the crop protection chemical compound II is Fluazaindolizine.
[0094] In another embodiment, crop protection chemical compound II is at least one of Flufiprol, Petition 870250102105, dated 07 / 11 / 2025, page 53 / 195 32 / 156 Nicofluprol and Piriprol. In one specific embodiment, crop protection chemical compound II is Flufiprol. In another embodiment, crop protection chemical compound II is Nicofluprol. In yet another embodiment, crop protection chemical compound II is Piriprol.
[0095] In another embodiment, the crop protection chemical compound II is at least one of Fluhexaphone, Bistriflurone, and Trifluenfuronate. In a specific embodiment, the crop protection chemical compound II is Fluhexaphone. In another embodiment, the crop protection chemical compound II is Bistriflurone. In another embodiment, the crop protection chemical compound II is Trifluenfuronate.
[0096] In an additional embodiment, the crop protection chemical compound II is Lotilaner.
[0097] In an additional embodiment, the crop protection chemical compound II is Indazapyroxamet.
[0098] In one embodiment, crop protection chemical compound II is at least one of one or more mineral oils that include paraffinic oils. In a specific embodiment, crop protection chemical compound II is a paraffinic oil.
[0099] In one embodiment, crop protection chemical compound II is at least one of Garlic extract, Bitter extract, Tea tree oil, and Clove oil. In one specific embodiment, crop protection chemical compound II is Garlic extract. In another embodiment, crop protection chemical compound II is Bitter extract. In yet another embodiment, crop protection chemical compound II is Tea tree oil. Petition 870250102105, dated 07 / 11 / 2025, page 54 / 195 33 / 156 In another application, the chemical compound II for crop protection is clove oil.
[0100] In one embodiment, crop protection chemical compound II is a monoterpene alcohol extracted from selected essential oils from a group comprising Citronella oil, Rose oil and Palmarosa oil. In a specific embodiment, crop protection chemical compound II is Geraniol.
[0101] In another embodiment, crop protection chemical compound II is at least one of Thymol and Citronella. In a specific embodiment, crop protection chemical compound II is Thymol. In another embodiment, crop protection chemical compound II is Citronella.
[0102] In one embodiment, crop protection chemical compound II is at least one of diatomaceous earth, amorphous silica, hydroxypropyl methylcellulose, kaolin (calcined), polydimethylsiloxane, and potassium salts of fatty acids. In a specific embodiment, crop protection chemical compound II is diatomaceous earth. In another embodiment, crop protection chemical compound II is amorphous silica. In another embodiment, crop protection chemical compound II is hydroxypropyl methylcellulose. In another embodiment, crop protection chemical compound II is kaolin (calcined). In another embodiment, crop protection chemical compound II is polydimethylsiloxane. In another embodiment, crop protection chemical compound II is potassium salts of fatty acids.
[0103] The weight ratio between Tau-fluvalinate and at least one crop protection compound II, as defined above, Petition 870250102105, dated 07 / 11 / 2025, page 55 / 195 34 / 156 varies depending on several conditions such as the type of formulation, climatic conditions, the type of crop and the type of pests.
[0104] In one embodiment, the weight ratio between Taufluvalinate and crop protection chemical compound II is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and crop protection chemical compound II is about 1:50 to 50:1.
[0105] The weight ratio between Tau-fluvalinate and crop protection chemical compound II may be any intermediate range selected from the ratios indicated above.
[0106] In one embodiment, the weight ratio between taufluvalinate and synthetic pyrethroid is about 1:100 to 100:1. In another embodiment, the weight ratio between taufluvalinate and synthetic pyrethroid is about 1:50 to 50:1. The weight ratio between taufluvalinate and synthetic pyrethroid may be any intermediate range selected from the ratios indicated above.
[0107] In one specific embodiment, the weight ratio between Tau-fluvalinate and Gamma-cyhalothrin is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Gamma-cyhalothrin is about 1:50 to 50:1.
[0108] In one specific embodiment, the weight ratio between Tau-fluvalinate and Alpha-cypermethrin is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Alpha-cypermethrin is about 1:50 to 50:1.
[0109] In one specific embodiment, the weight ratio between Tau-fluvalinate and Etofenprox is about 1:100 to 100:1. In Petition 870250102105, dated 07 / 11 / 2025, p. 56 / 195 35 / 156 In another form, the weight ratio between Tau-fluvalinate and Etofenprox is approximately 1:50 to 50:1.
[0110] In one specific embodiment, the weight ratio between Tau-fluvalinate and Tefluthrin is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Tefluthrin is about 1:50 to 50:1.
[0111] In one embodiment, the weight ratio between Taufluvalinate and Competitive modulator of nicotinic acetylcholine receptor (nAChR) is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Competitive modulator of nicotinic acetylcholine receptor (nAChR) is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Competitive modulator of nicotinic acetylcholine receptor (nAChR) may be any intermediate range selected from the ratios indicated above.
[0112] In one specific embodiment, the weight ratio between Tau-fluvalinate and Flupiradifurone is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Flupiradifurone is about 1:50 to 50:1.
[0113] In one specific embodiment, the weight ratio between Tau-fluvalinate and Flupirimine is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Flupirimine is about 1:50 to 50:1.
[0114] In one particular embodiment, the weight ratio between Tau-fluvalinate and Flupirimine is about 1:10 to 10:1.
[0115] In one specific embodiment, the weight ratio between Tau-fluvalinate and Triflumezopyrim is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Triflumezopyrim is about 1:50 to 50:1. Petition 870250102105, dated 07 / 11 / 2025, page 57 / 195 36 / 156
[0116] In one embodiment, the weight ratio between Taufluvalinate and Uncoupler of oxidative phosphorylation via proton gradient disruption is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Uncoupler of oxidative phosphorylation via proton gradient disruption is about 1:50 to 50:1. The weight ratio between Tau-fluvalinate and Uncoupler of oxidative phosphorylation via proton gradient disruption may be any intermediate range selected from the ratios indicated above.
[0117] In one specific embodiment, the weight ratio between Tau-fluvalinate and Chlorfenapyr is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Chlorfenapyr is about 1:50 to 50:1.
[0118] In one specific embodiment, the weight ratio between Tau-fluvalinate and Brochlorfenapyr is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Brochlorfenapyr is about 1:50 to 50:1.
[0119] In one embodiment, the weight ratio between Taufluvalinate and Ryanodine receptor modulator is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Ryanodine receptor modulator is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Ryanodine receptor modulator may be any intermediate range selected from the ratios indicated above.
[0120] In one specific embodiment, the weight ratio between Tau-fluvalinate and Tetrachloroantraniliprole is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau Petition 870250102105, dated 07 / 11 / 2025, p. 58 / 195 The ratio of fluvalinate to tetrachloroantraniliprole (37 / 156) is approximately 1:50 to 50:1.
[0121] In one specific embodiment, the weight ratio between Tau-fluvalinate and Thiotraniliprole is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Thiotraniliprole is about 1:50 to 50:1.
[0122] In one embodiment, the weight ratio between Taufluvalinate and Nicotinic Acetylcholine Receptor Channel Blocker is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Nicotinic Acetylcholine Receptor Channel Blocker is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Nicotinic Acetylcholine Receptor Channel Blocker may be any intermediate range selected from the ratios indicated above.
[0123] In one specific embodiment, the weight ratio between Tau-fluvalinate and Bensultape is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Bensultape is about 1:50 to 50:1.
[0124] In one specific embodiment, the weight ratio between Taufluvalinate and Cartap hydrochloride is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Cartap hydrochloride is about 1:50 to 50:1.
[0125] In one specific embodiment, the weight ratio between Tau-fluvalinate and Thiocyclam is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Thiocyclam is about 1:50 to 50:1.
[0126] In one particular embodiment, the weight ratio between Tau-fluvalinate and Tissultape-sodium is about 1:100 a Petition 870250102105, dated 07 / 11 / 2025, p. 59 / 195 38 / 156 100:1. In another embodiment, the weight ratio between Taufluvalinate and Tissultap-sodium is approximately 1:50 to 50:1.
[0127] In one embodiment, the weight ratio between Taufluvalinate and Mitochondrial Electron Transport Inhibitor (METI) is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Mitochondrial Electron Transport Inhibitor (METI) is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Mitochondrial Electron Transport Inhibitor (METI) may be any intermediate range selected from the ratios indicated above.
[0128] In one specific embodiment, the weight ratio between Taufluvalinate and Phenazaquine is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Phenazaquine is about 1:50 to 50:1.
[0129] In one specific embodiment, the weight ratio between Tau-fluvalinate and Pyridaben is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Pyridaben is about 1:50 to 50:1.
[0130] In one specific embodiment, the weight ratio between Tau-fluvalinate and Pirimidifen is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Pirimidifen is about 1:50 to 50:1.
[0131] In one specific embodiment, the weight ratio between Tau-fluvalinate and Tebufenpyrad is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Tebufenpyrad is about 1:50 to 50:1.
[0132] In one particular embodiment, the weight ratio between Tau-fluvalinate and Cietpirafene is about 1:100 to 100:1. Petition 870250102105, dated 07 / 11 / 2025, p. 60 / 195 39 / 156 In another embodiment, the weight ratio between Taufluvalinate and Cietpirafene is approximately 1:50 to 50:1.
[0133] In one embodiment, the weight ratio between Taufluvalinate and a meta-diamide insecticide is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and a meta-diamide insecticide is about 1:50 to 50:1. The weight ratio between Tau-fluvalinate and a meta-diamide insecticide may be any intermediate range selected from the ratios indicated above.
[0134] In one specific embodiment, the weight ratio between Tau-fluvalinate and Fluxamethamide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Fluxamethamide is about 1:50 to 50:1.
[0135] In one specific embodiment, the weight ratio between Tau-fluvalinate and Isocycloseram is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Isocycloseram is about 1:50 to 50:1.
[0136] In one particular embodiment, the weight ratio between Tau-fluvalinate and Isocycloseram is about 1:1 to 5:1.
[0137] In one embodiment, the weight ratio between Taufluvalinate and broad-spectrum insect growth regulator is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and broad-spectrum insect growth regulator is about 1:50 to 50:1. The weight ratio between Tau-fluvalinate and broad-spectrum insect growth regulator may be any intermediate range selected from the ratios indicated above.
[0138] In one particular embodiment, the weight ratio between Tau-fluvalinate and Fenoxycarb is about 1:100 to 100:1. Petition 870250102105, dated 07 / 11 / 2025, page 61 / 195 40 / 156 In another embodiment, the weight ratio between taufluvalinate and phenoxycarb is approximately 1:50 to 50:1.
[0139] In one embodiment, the weight ratio between Taufluvalinate and Glutamate-gated chloride channel allosteric modulator (GluCl) is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Glutamate-gated chloride channel allosteric modulator (GluCl) is about 1:50 to 50:1. The weight ratio between Tau-fluvalinate and Glutamate-gated chloride channel allosteric modulator (GluCl) may be any intermediate range selected from the ratios indicated above.
[0140] In one specific embodiment, the weight ratio between Taufluvalinate and Milbemectin is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Milbemectin is about 1:50 to 50:1.
[0141] In one specific embodiment, the weight ratio between Taufluvalinate and Lepimectin is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Lepimectin is about 1:50 to 50:1.
[0142] In one embodiment, the weight ratio between Taufluvalinate and Voltage-gated sodium channel blocker is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Voltage-gated sodium channel blocker is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Voltage-gated sodium channel blocker may be any intermediate range selected from the ratios indicated above. Petition 870250102105, dated 07 / 11 / 2025, page 62 / 195 41 / 156
[0143] In one specific embodiment, the weight ratio between Taufluvalinate and Metaflumizone is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Metaflumizone is about 1:50 to 50:1.
[0144] In one embodiment, the weight ratio between Taufluvalinate and Chitin biosynthesis inhibitor affecting CHS1 is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Chitin biosynthesis inhibitor affecting CHS1 is about 1:50 to 50:1. The weight ratio between Tau-fluvalinate and Chitin biosynthesis inhibitor affecting CHS1 may be any intermediate range selected from the ratios indicated above.
[0145] In one specific embodiment, the weight ratio between Tau-fluvalinate and Diflubenzurone is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Diflubenzurone is about 1:50 to 50:1.
[0146] In one specific embodiment, the weight ratio between Tau-fluvalinate and Flufenoxurone is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Flufenoxurone is about 1:50 to 50:1.
[0147] In one specific embodiment, the weight ratio between Tau-fluvalinate and Lufenuron is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Lufenuron is about 1:50 to 50:1.
[0148] In one specific embodiment, the weight ratio between Tau-fluvalinate and Teflubenzurone is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Teflubenzurone is about 1:50 to 50:1.
[0149] In one particular embodiment, the weight ratio between Tau-fluvalinate and Chlorfluazurone is about 1:100 to 100:1. Petition 870250102105, dated 07 / 11 / 2025, p. 63 / 195 42 / 156 In another embodiment, the weight ratio between Taufluvalinate and Chlorfluazurone is approximately 1:50 to 50:1.
[0150] In one embodiment, the weight ratio between Taufluvalinate and Acetyl CoA carboxylase inhibitor is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Acetyl CoA carboxylase inhibitor is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Acetyl CoA carboxylase inhibitor may be any intermediate range selected from the ratios indicated above.
[0151] In one specific embodiment, the weight ratio between Taufluvalinate and Spidoxamate is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Spidoxamate is about 1:50 to 50:1.
[0152] In one specific embodiment, the weight ratio between Tau-fluvalinate and Spirodiclofen is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Spirodiclofen is about 1:50 to 50:1.
[0153] In one specific embodiment, the weight ratio between Tau-fluvalinate and Spiromesifene is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Spiromesifene is about 1:50 to 50:1.
[0154] In one embodiment, the weight ratio between Taufluvalinate and Entomopathogenic Fungal Agent is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Entomopathogenic Fungal Agent is about 1:50 to 50:1. The weight ratio between Tau-fluvalinate and Entomopathogenic Fungal Agent may be any intermediate range selected from the ratios indicated above. Petition 870250102105, dated 07 / 11 / 2025, page 64 / 195 43 / 156
[0155] In one specific embodiment, the weight ratio between Tau-fluvalinate and Beauveria spp. is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Beauveria spp. is about 1:50 to 50:1.
[0156] In one specific embodiment, the weight ratio between Tau-fluvalinate and Metarhizium spp. is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Metarhizium spp. is about 1:50 to 50:1.
[0157] In one specific embodiment, the weight ratio between Tau-fluvalinate and Paecilomyces spp. is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Paecilomyces spp. is about 1:50 to 50:1.
[0158] In one embodiment, the weight ratio between Taufluvalinate and Granulovirus is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Granulovirus is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Granulovirus may be any intermediate range selected from the ratios indicated above.
[0159] In one specific embodiment, the weight ratio between Tau-fluvalinate and GV of Cydia pomonella is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and GV of Cydia pomonella is about 1:50 to 50:1.
[0160] In one specific embodiment, the weight ratio between Tau-fluvalinate and GV of Thaumatotibia leucotreta is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and GV of Thaumatotibia leucotreta is about 1:50 to 50:1.
[0161] In one embodiment, the weight ratio between Taufluvalinate and Nucleopolyhedrosis Virus is approximately 1:100 Petition 870250102105, dated 07 / 11 / 2025, page 65 / 195 44 / 156 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Nucleopolyhedrosis Virus is approximately 1:50 to 50:1. The weight ratio between Taufluvalinate and Nucleopolyhedrosis Virus may be any intermediate range selected from the ratios indicated above.
[0162] In one specific embodiment, the weight ratio between Tau-fluvalinate and MNPV of Anticarsia gemmatalis is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and MNPV of Anticarsia gemmatalis is about 1:50 to 50:1.
[0163] In one specific embodiment, the weight ratio between Tau-fluvalinate and NPV of Helicoverpa armigera is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and NPV of Helicoverpa armigera is about 1:50 to 50:1.
[0164] In one embodiment, the weight ratio between Taufluvalinate and Mitochondrial Complex II Electron Transport Inhibitors - Qi site is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Mitochondrial Complex II Electron Transport Inhibitors - Qi site is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Mitochondrial Complex II Electron Transport Inhibitors - Qi site may be any intermediate range between the ratios indicated above.
[0165] In one specific embodiment, the weight ratio between Taufluvalinate and Flomethoquine is approximately 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Flomethoquine is approximately 1:50 to 50:1. Petition 870250102105, dated 07 / 11 / 2025, page 66 / 195 45 / 156
[0166] In one embodiment, the weight ratio between Taufluvalinate and Chitin Biosynthesis Inhibitor (Type 1) is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Chitin Biosynthesis Inhibitor (Type 1) is about 1:50 to 50:1. The weight ratio between Tau-fluvalinate and Chitin Biosynthesis Inhibitor (Type 1) may be any intermediate range selected from the ratios indicated above.
[0167] In one specific embodiment, the weight ratio between Tau-fluvalinate and Buprofezin is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Buprofezin is about 1:50 to 50:1.
[0168] In one embodiment, the weight ratio between Taufluvalinate and Ecdysone Receptor is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Ecdysone Receptor is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Ecdysone Receptor may be any intermediate range selected from the ratios indicated above.
[0169] In one specific embodiment, the weight ratio between Taufluvalinate and Cromafenozide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Cromafenozide is about 1:50 to 50:1.
[0170] In one specific embodiment, the weight ratio between Tau-fluvalinate and Halofenozide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Halofenozide is about 1:50 to 50:1.
[0171] In one particular embodiment, the weight ratio between Tau-fluvalinate and Methoxyfenozide is about 1:100 to 100:1. Petition 870250102105, dated 07 / 11 / 2025, page 67 / 195 46 / 156 In another embodiment, the weight ratio between Taufluvalinate and Methoxyfenozide is approximately 1:50 to 50:1.
[0172] In one specific embodiment, the weight ratio between Tau-fluvalinate and Tebufenozide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Tebufenozide is about 1:50 to 50:1.
[0173] In one embodiment, the weight ratio between Taufluvalinate and Mitochondrial Complex III electron transport inhibitor (Qo site) is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Mitochondrial Complex III electron transport inhibitor (Qo site) is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Mitochondrial Complex III electron transport inhibitor (Qo site) may be any intermediate range between the ratios indicated above.
[0174] In one specific embodiment, the weight ratio between Tau-fluvalinate and Acequinocil is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Acequinocil is about 1:50 to 50:1.
[0175] In one specific embodiment, the weight ratio between Tau-fluvalinate and Fluacripirim is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Fluacripirim is about 1:50 to 50:1.
[0176] In one specific embodiment, the weight ratio between Tau-fluvalinate and Hydramethylnone is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Hydramethylnone is about 1:50 to 50:1.
[0177] In one embodiment, the weight ratio between Taufluvalinate and Cyclotide insecticide is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau Petition 870250102105, dated 07 / 11 / 2025, page 68 / 195 The ratio of 47 / 156 fluvalinate to cyclotide insecticide is approximately 1:50 to 50:1. The weight ratio between tau-fluvalinate and cyclotide insecticide may be any intermediate range selected from the ratios indicated above.
[0178] In one specific embodiment, the weight ratio between Tau-fluvalinate and Clitoria ternatea is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Clitoria ternatea is about 1:50 to 50:1.
[0179] In one embodiment, the weight ratio between Taufluvalinate and Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulator (site II) is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulator (site II) is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulator (site II) may be any intermediate range selected from the ratios indicated above.
[0180] In one specific embodiment, the weight ratio between Tau-fluvalinate and GS-omega / kappa HXTX-Hv1a peptide is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and GS-omega / kappa HXTXHv1a peptide is about 1:50 to 50:1.
[0181] In one embodiment, the weight ratio between Taufluvalinate and Calcium-activated potassium channel modulator (KCa2) is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Calcium-activated potassium channel modulator (KCa2) is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Calcium-activated potassium channel modulator (KCa2) Petition 870250102105, dated 07 / 11 / 2025, page 69 / 195 48 / 156 can be any intermediate range selected from the ratios indicated above.
[0182] In one specific embodiment, the weight ratio between Tau-fluvalinate and Acinonapyr is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Acinonapyr is about 1:50 to 50:1.
[0183] In one embodiment, the weight ratio between Taufluvalinate and the synergistic insecticidal agent is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and the synergistic insecticidal agent is about 1:50 to 50:1. The weight ratio between Taufluvalinate and the synergistic insecticidal agent may be any intermediate range selected from the ratios indicated above.
[0184] In one specific embodiment, the weight ratio between Tau-fluvalinate and N-octyl bicyclic heptene dicarboxamide (MGK-264) is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and N-octyl bicyclic heptene dicarboxamide (MGK-264) is about 1:50 to 50:1.
[0185] In one specific embodiment, the weight ratio between Tau-fluvalinate and Piprotal is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Piprotal is about 1:50 to 50:1.
[0186] In one specific embodiment, the weight ratio between Tau-fluvalinate and Propyl isosome is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Propyl isosome is about 1:50 to 50:1.
[0187] In one particular embodiment, the weight ratio between Tau-fluvalinate and Sesamex is about 1:100 to 100:1. In Petition 870250102105, dated 07 / 11 / 2025, p. 70 / 195 49 / 156 another modality, the weight ratio between Tau-fluvalinate and Sesamex is about 1:50 to 50:1.
[0188] In one specific embodiment, the weight ratio between Tau-fluvalinate and Sesamolin is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Sesamolin is about 1:50 to 50:1.
[0189] In one specific embodiment, the weight ratio between Tau-fluvalinate and Sulfoxide is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Sulfoxide is about 1:50 to 50:1.
[0190] In one embodiment, the weight ratio between Taufluvalinate and Fungicide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Fungicide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Fungicide may be any intermediate range selected from the ratios indicated above.
[0191] In one specific embodiment, the weight ratio between Tau-fluvalinate and Pidiflumethophene is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Pidiflumethophene is about 1:50 to 50:1.
[0192] In one specific embodiment, the weight ratio between Tau-fluvalinate and Fluazinam is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Fluazinam is about 1:50 to 50:1.
[0193] In one specific embodiment, the weight ratio between Tau-fluvalinate and Fluxapyroxad is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Fluxapyroxad is about 1:50 to 50:1.
[0194] In one specific embodiment, the weight ratio between Tau-fluvalinate and Difenoconazole is approximately 1:100 to 100:1. Petition 870250102105, dated 07 / 11 / 2025, p. 71 / 195 50 / 156 In another embodiment, the weight ratio between Taufluvalinate and Difenoconazole is approximately 1:50 to 50:1.
[0195] In one specific embodiment, the weight ratio between Tau-fluvalinate and Tebuconazole is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Tebuconazole is about 1:50 to 50:1.
[0196] In one specific embodiment, the weight ratio between Tau-fluvalinate and Fludioxonil is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Fludioxonil is about 1:50 to 50:1.
[0197] In one specific embodiment, the weight ratio between Tau-fluvalinate and Azoxystrobin is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Azoxystrobin is about 1:50 to 50:1.
[0198] In one specific embodiment, the weight ratio between Tau-fluvalinate and Mancozeb is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Mancozeb is about 1:50 to 50:1.
[0199] In one embodiment, the weight ratio between Taufluvalinate and Neonicotinoid Insecticide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Neonicotinoid Insecticide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Neonicotinoid Insecticide may be any intermediate range selected from the ratios indicated above.
[0200] In one specific embodiment, the weight ratio between Taufluvalinate and Cycloxapride is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Cycloxapride is about 1:50 to 50:1. Petition 870250102105, dated 07 / 11 / 2025, p. 72 / 195 51 / 156
[0201] In one specific embodiment, the weight ratio between Tau-fluvalinate and Guadipyr is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Guadipyr is about 1:50 to 50:1.
[0202] In one specific embodiment, the weight ratio between Taufluvalinate and Imidaclotz is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Imidaclotz is about 1:50 to 50:1.
[0203] In one embodiment, the weight ratio between Taufluvalinate and Acaricide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Acaricide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Acaricide may be any intermediate range selected from the ratios indicated above.
[0204] In one specific embodiment, the weight ratio between Tau-fluvalinate and Cyflumethophene is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Cyflumethophene is about 1:50 to 50:1.
[0205] In one specific embodiment, the weight ratio between Tau-fluvalinate and Sila-Ciflumethophene is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Sila-Ciflumethophene is about 1:50 to 50:1.
[0206] In one embodiment, the weight ratio between Taufluvalinate and Diamide Insecticide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Diamide Insecticide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Diamide Insecticide may be any intermediate range selected from the ratios indicated above. Petition 870250102105, dated 07 / 11 / 2025, page 73 / 195 52 / 156
[0207] In one specific embodiment, the weight ratio between Taufluvalinate and Ciproflanilide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Ciproflanilide is about 1:50 to 50:1.
[0208] In one embodiment, the weight ratio between Taufluvalinate and Mesoionic Insecticide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Mesoionic Insecticide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Mesoionic Insecticide may be any intermediate range selected from the ratios indicated above.
[0209] In one specific embodiment, the weight ratio between Tau-fluvalinate and Dichloromezotiaz is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Dichloromezotiaz is about 1:50 to 50:1.
[0210] In one specific embodiment, the weight ratio between Tau-fluvalinate and Fenmezoditiaz is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Fenmezoditiaz is about 1:50 to 50:1.
[0211] In one embodiment, the weight ratio between Taufluvalinate and Pyrazole Carboxamide Insecticide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Pyrazole Carboxamide Insecticide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Pyrazole Carboxamide Insecticide may be any intermediate range selected from the ratios indicated above.
[0212] In one particular embodiment, the weight ratio between Tau-fluvalinate and Dimpropiridaz is about 1:100 to 100:1. Petition 870250102105, dated 07 / 11 / 2025, page 74 / 195 53 / 156 In another embodiment, the weight ratio between Taufluvalinate and Dimpropiridaz is approximately 1:50 to 50:1.
[0213] In one specific embodiment, the weight ratio between Tau-fluvalinate and Ticlopyrazoflor is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Ticlopyrazoflor is about 1:50 to 50:1.
[0214] In one specific embodiment, the weight ratio between Tau-fluvalinate and Fluchlordiniliprole is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Fluchlordiniliprole is about 1:50 to 50:1.
[0215] In one embodiment, the weight ratio between Taufluvalinate and Sulfonamide Nematicide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Sulfonamide Nematicide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Sulfonamide Nematicide may be any intermediate range selected from the ratios indicated above.
[0216] In one specific embodiment, the weight ratio between Tau-fluvalinate and Fluazaindolizine is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Fluazaindolizine is about 1:50 to 50:1.
[0217] In one embodiment, the weight ratio between Taufluvalinate and Phenylpyrazole is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Phenylpyrazole is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Phenylpyrazole may be any intermediate range selected from the ratios indicated above.
[0218] In one specific embodiment, the weight ratio between Tau-fluvalinate and Flufiprol is approximately 1:100 to 100:1. In Petition 870250102105, dated 07 / 11 / 2025, page 75 / 195 54 / 156 another form, the weight ratio between Tau-fluvalinate and Flufiprol is approximately 1:50 to 50:1.
[0219] In one specific embodiment, the weight ratio between Tau-fluvalinate and Nicofluprol is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Nicofluprol is about 1:50 to 50:1.
[0220] In one specific embodiment, the weight ratio between Tau-fluvalinate and Piriprole is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Piriprole is about 1:50 to 50:1.
[0221] In one embodiment, the weight ratio between Taufluvalinate and Fluorine-containing Insecticide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Fluorine-containing Insecticide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Fluorine-containing Insecticide may be any intermediate range selected from the ratios indicated above.
[0222] In one specific embodiment, the weight ratio between Tau-fluvalinate and Fluhexaphone is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Fluhexaphone is about 1:50 to 50:1.
[0223] In one specific embodiment, the weight ratio between Tau-fluvalinate and Bistriflurone is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Bistriflurone is about 1:50 to 50:1.
[0224] In one specific embodiment, the weight ratio between Tau-fluvalinate and Trifluenfuronate is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Trifluenfuronate is about 1:50 to 50:1. Petition 870250102105, dated 07 / 11 / 2025, page 76 / 195 55 / 156
[0225] In one embodiment, the weight ratio between Taufluvalinate and Isoxazoline Parasiticide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Isoxazoline Parasiticide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Isoxazoline Parasiticide may be any intermediate range selected from the ratios indicated above.
[0226] In one specific embodiment, the weight ratio between Tau-fluvalinate and Lotilaner is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Lotilaner is about 1:50 to 50:1.
[0227] In one embodiment, the weight ratio between Taufluvalinate and Indazole Insecticide is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Indazole Insecticide is about 1:50 to 50:1. The weight ratio between Taufluvalinate and Indazole Insecticide may be any intermediate range selected from the ratios indicated above.
[0228] In one specific embodiment, the weight ratio between Tau-fluvalinate and Indazapyroxamet is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Indazapyroxamet is about 1:50 to 50:1.
[0229] In one embodiment, the weight ratio between Taufluvalinate and one or more Mineral Oils is from about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and one or more Mineral Oils is from about 1:50 to 50:1. The weight ratio between Taufluvalinate and one or more Mineral Oils may be any intermediate range selected from the ratios indicated above. Petition 870250102105, dated 07 / 11 / 2025, p. 77 / 195 56 / 156
[0230] In one specific embodiment, the weight ratio between Tau-fluvalinate and paraffinic oils is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and paraffinic oils is about 1:50 to 50:1.
[0231] In one embodiment, the weight ratio between Taufluvalinate and plant extract is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and plant extract is about 1:50 to 50:1. The weight ratio between Taufluvalinate and plant extract may be any intermediate range selected from the ratios indicated above.
[0232] In one specific embodiment, the weight ratio between Tau-fluvalinate and Garlic Extract is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Garlic Extract is about 1:50 to 50:1.
[0233] In one particular embodiment, the weight ratio between Tau-fluvalinate and Garlic Extract is about 1:1.
[0234] In one specific embodiment, the weight ratio between Tau-fluvalinate and Bitterberry Extract is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Bitterberry Extract is about 1:50 to 50:1.
[0235] In one specific embodiment, the weight ratio between Tau-fluvalinate and Tea tree oil is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Tea tree oil is about 1:50 to 50:1.
[0236] In one specific embodiment, the weight ratio between Tau-fluvalinate and Eugenol, i.e., Clove extract, is about 1:100 to 100:1. In another embodiment, the ratio in Petition 870250102105, dated 07 / 11 / 2025, page 78 / 195 The ratio of tau-fluvalinate to eugenol to clove extract is approximately 1:50 to 50:1.
[0237] In one specific embodiment, the weight ratio between Tau-fluvalinate and Citronella oil is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Citronella oil is about 1:50 to 50:1.
[0238] In one specific embodiment, the weight ratio between Tau-fluvalinate and Rose Oil is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Rose Oil is about 1:50 to 50:1.
[0239] In one specific embodiment, the weight ratio between Tau-fluvalinate and Palmarosa oil is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Palmarosa oil is about 1:50 to 50:1.
[0240] In one specific embodiment, the weight ratio between Tau-fluvalinate and Palmarosa oil is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and Geraniol is about 1:50 to 50:1.
[0241] In one embodiment, the weight ratio between Taufluvalinate and repellent is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and repellent is about 1:50 to 50:1. The weight ratio between Tau-fluvalinate and repellent may be any intermediate range selected from the ratios indicated above.
[0242] In one specific embodiment, the weight ratio between Tau-fluvalinate and Thymol is about 1:100 to 100:1. In another embodiment, the weight ratio between Tau-fluvalinate and Thymol is about 1:50 to 50:1.
[0243] In one specific embodiment, the weight ratio between Tau-fluvalinate and Citronella is about 1:100 to 100:1. In Petition 870250102105, dated 07 / 11 / 2025, p. 79 / 195 58 / 156 another form, the weight ratio between Tau-fluvalinate and Citronella is about 1:50 to 50:1.
[0244] In one embodiment, the weight ratio between Taufluvalinate and one or more agrochemically acceptable additives selected from a group comprising Diatomaceous Earth, Amorphous Silica, Hydroxypropylmethylcellulose, Kaolin (calcined), Polydimethylsiloxane and Potassium Salts of Fatty Acids is about 1:100 to 100:1. In another embodiment, the weight ratio between Taufluvalinate and the additives is about 1:50 to 50:1. The weight ratio between Taufluvalinate and the additives may be any intermediate range selected from the ratios indicated above.
[0245] In one embodiment, the mixture combination of the present invention may be applied pre-sowing or post-sowing, pre-emergence or early post-emergence of the crop. The mixture combination may be applied by furrow spraying, foliar application, spreading, basal application, soil application, soil incorporation or soil injection.
[0246] In another embodiment, the mixture combination is applied to uncultivated areas which include, but are not limited to, commercial areas, residential areas, lawns, ornamental plants, shrubs, trees, parks, livestock areas, warehouses, food storage facilities, grain bins, grass, pastures, prairies, grazing land, fallow land, rights of way, golf courses, parks, along roads, power lines, pipelines, railways, forests, well sites and equipment yards. Petition 870250102105, dated 07 / 11 / 2025, page 80 / 195 59 / 156
[0247] In yet another category, plants include vegetables and greens, such as tomatoes, peppers, cabbage, broccoli, lettuce, spinach, cauliflower, cucurbits, melon, watermelon, cucumbers, carrots, onions, potatoes, tobacco, pome fruits and stone fruits, nuts, kiwi, berries, olives, almonds, pineapples, apples, pears, plums, peaches and cherries, table and wine grapes, citrus fruits such as oranges, lemons, grapefruits and limes, cotton, soybeans, rapeseed, nuts, wheat, barley, corn, sorghum, sunflower, peanuts, rice, pasture, maize, coffee, beans, peas, cassava, sugarcane, cloves, peppers and ornamental plants such as roses.
[0248] In a further embodiment, plants include cultivated plants that tolerate the action of herbicides, fungicides or insecticides as a result of breeding methods and / or genetic manipulation.
[0249] In one embodiment, the insect pests are of the order Coleoptera, such as Acanthoscelides spp. (weevils), Acanthoscelides obtectus (common bean weevil), Agrilus planipennis (green ash borer), Agriotes spp. (wireworms), Anoplophora glabripennis (Asian longhorn beetle), Anthonomus spp. (weevils), Anthonomus grandis (cotton boll weevil), Aphidius spp., Apion spp. (weevils), Apogonia spp. (larvae), Ataenius spretulus (black grass ataenius), Atomaria linearis (pygmy mangel beetle), Aulacophore spp., Bothynoderes punctiventris (beetroot weevil), Bruchus spp. (weevils), Bruchus pisorum (pea weevil), Cacoesia spp., Callosobruchus maculatus (wigna bean weevil), Carpophilus hemiptera (fruit beetle) Petition 870250102105, dated 07 / 11 / 2025, page 81 / 195 60 / 156 dry), Cassida vittata, Cerosterna spp., Cerotoma spp. (chrysomelid beetles), Cerotoma trifurcata (bean leaf beetle), Ceutorhynchus spp. (weevils), Ceutorhynchus assimilis (cabbage seed weevil), Ceutorhynchus napi (cabbage weevil), Chaetocnema spp. (chrysomelids), Colaspis spp. (ground beetles), Conoderus scalaris, Conoderus stigmosus, Conotrachelus nenuphar (plum weevil), Cotinus nitidis (June green beetle), Crioceris asparagi (asparagus beetle), Cryptolestes ferrugineus (rust beetle), Cryptolestes pusillus (flat grain beetle), Cryptolestes turcicus (Turkish grain beetle), Ctenicera spp. (wireworms), Curculio spp. (weevils), Cyclocephala spp. (larvae), Cylindrocpturus adspersus (sunflower stem weevil), Deporaus marginatus (mango leaf-cutting weevil), Dermestes lardarius (bacon beetle), Dermestes macules (leather beetle), Diabrotica spp. (chrysomelids), Epilachna varivestis (Mexican bean beetle), Faustinus cubae, Hylobius pales (pales weevil), Hypera spp. (weevils), Hypera postica (alfalfa weevil), Hyperodes spp. (Hyperodes weevil), Hypothenemus hampei (coffee borer), Ips spp.(recording beetles), Lasioderma serricorne (smoke beetle), Leptinotarsa decemlineata (Colorado potato beetle), Liogenys futscus, Liogenys suturalis, Lissorhoptrus oryzophilus (rice water weevil), Lyctus spp. (wood borers / dust beetles), Maecolaspis joliveti, Megascelis spp., Melanotus communis, Meligethes spp., Meligethes aeneus (flower beetle), Melolontha (May beetle), Oberea brevis, Oberea linearis, Oryctes rhinoceros (beetle). Petition 870250102105, dated 07 / 11 / 2025, page 82 / 195 61 / 156 rhinoceros), Oryzaephilus mercator (merchant grain beetle), Oryzaephilus surinamensis (Suriname weevil), Otiorhynchus spp. (weevils), Oulema melanopus (cereal leaf beetle), Oulema oryzae, Pantomorus spp. (weevils), Phyllophaga spp. (May / June beetle), Phyllophaga cuyabana, Phyllotreta spp. (chrysomelid beetles), Phynchites spp., Popillia japonica (Japanese beetle), Prostephanus truncates (greater grain borer), Rhizopertha dominica (lesser grain borer), Rhizotrogus spp. (European beetle), Rhynchophorus spp. (weevils), Scolytus spp. (wood beetles), Shenophorus spp. (wood weevil), Sitona lineatus (pea leaf weevil), Sitophilus spp. (grain weevils), Sitophilus granaries (wheat weevil), Sitophilus oryzae (rice weevil), Stegobium paniceum (flour weevil), Tribolium spp.(flour beetles), Tribolium castaneum (red flour beetle), Tribolium confusum (confused flour beetle), Trogoderma variabile (warehouse beetle) and Zabrus tenebioides.
[0250] In yet another category, insect pests are of the order Diptera, such as Aedes spp. (mosquitoes), Agromyza frontella (alfalfa leafminer), Agromyza spp. (leafminers), Anastrepha spp. (fruit flies), Anastrepha suspensa (Caribbean fruit fly), Anopheles spp. (mosquitoes), Batrocera spp. (fruit flies), Bactrocera cucurbitae (melon fly), Bactrocera dorsalis (oriental fruit fly), B. tryoni, Ceratitis spp. (fruit flies), Ceratitis capitata (Mediterranean fruit fly), Chrysops spp. (deer flies), Cocliliomyia spp. (screwworms), Contarinia spp. (gall flies), Culex spp. (mosquitoes), Dasineura spp. (mosquitoes) Petition 870250102105, dated 07 / 11 / 2025, page 83 / 195 62 / 156 (gallfly), Dasineura brassicae (cabbage gallfly), Delia spp., Delia platura (corn larva), Drosophila spp. (vinegar flies), Fannia spp. (dirt flies), Fannia canicularis (housefly), Fannia scalaris (latrine fly), Gasterophilus intestinalis (horsefly), Gracillia perseae, Haematobia irritans (horn fly), Hylemyia spp. (root larvae), Hypoderma lineatum (common cattle larva), Liriomyza spp. (leafminers), Liriomyza brassica (serpentine leafminer), Melophagus ovinus (sheep flies), Musca spp. (muscid flies), Musca autumnalis (face fly), Musca domestica (house fly), Oestrus ovis (sheep fly), Oscinella frit (grass fly), Pegomyia betae (beet leaf miner), Phorbia spp., Psila rosae (carrot rust fly), Rhagoletis cerasi (cherry fruit fly), Rhagoletis pomonella (apple larva), Sitodiplosis mosellana (orange wheat flower fly), Stomoxys calcitrans (stable fly), Tabanus spp. (stable flies) and Tipula spp. (crane flies).
[0251] In yet another category, insect pests are of the order Hemiptera, such as Acrosternum hilare (green stink bug), Blissus leucopterus (grass stink bug), Calocoris norvegicus (potato mirid), Cimex hemipterus (tropical bed bug), Cimex lectularius (bed bug), Dagbertus fasciatus, Dichelops furcatus, Dysdercus suturellus (cotton spotter), Edessa meditabunda, Eurygaster maura (grain stink bug), Euschistus heros, Euschistus servus (brown stink bug), Helopeltis antonii, Helopeltis theivora (mosquito Petition 870250102105, dated 07 / 11 / 2025, p. 84 / 195 63 / 156 of tea), Lagynotomus spp. (bed bugs), Leptocorisa oratorius, Leptocorisa varicornis, Lygus spp. (plant bugs), Lygus hesperus (cotton bug), Maconellicoccus hirsutus, Neurocolpus longirostris, Nezara viridula (southern green stink bug), Paratrioza cockerelli, Bactericera cockerelli, Phytocoris spp. (plant bugs), Nysius spp., Phytocoris californicus, Phytocoris relativus, Piezodorus guildingi, Poecilocapsus lineatus (four-lined stink bug), Psallus vaccinicola, Pseudacysta perseae, Scaptocoris castanea and Triatoma spp. (blood-sucking bugs / kissing bugs).
[0252] In yet another category, insect pests are of the order Homoptera, such as Acrythosiphon pisum (pea aphid), Adelges spp. (aphids), Aleurodes proletella (cabbage whitefly), Aleurodicus disperses, Aleurothrixus floccosus (citrus whitefly), Aluacaspis spp., Amrasca bigutella, Aphrophora spp. (leafhoppers), Aonidiella aurantii (red scale insect), Aphis spp. (aphids), Aphis gossypii (cotton aphid), Aphis pomi (apple aphid), Aulacorthum solani (foxglove aphid), Bemisia spp. (whiteflies), Bemisia argentifolii, Bemisia tabaci (sweet potato whitefly), Brachycolus noxius (Russian aphid), Brachycorynella asparagi (asparagus aphid), Brevennia rehi, Brevicoryne brassicae (cabbage aphid), Ceroplastes spp. (mealybugs), Ceroplastes rubens (red waxy scale), Chionaspis spp. (mealybugs), Chrysomphalus spp. (mealybugs), Coccus spp.(mealybugs), Dysaphis plantaginea (gray apple aphid), Empoasca spp. (leafhoppers), Eriosoma lanigerum (woolly aphid of Petition 870250102105, dated 07 / 11 / 2025, page 85 / 195 64 / 156 Rosaceae), Icerya purchasi (white aphid), Idioscopus nitidulus (mango leafhopper), Laodelphax striatellus (small brown fulgoromorph), Lepidosaphes spp., Macrosiphum spp., Macrosiphum euphorbiae (potato aphid), Macrosiphum granarium (ear aphid), Macrosiphum rosae (purple rose aphid), Macrosteles quadrilineatus (six-spotted leafhopper), Mahanarva frimbiolata, Metopolophium dirhodum (leaf aphid), Mictis longicornis, Myzus persicae (green peach aphid), Nephotettix spp. (leafhoppers), Nephotettix cinctipes (green leafhopper), Nilaparvata lugens (brown mealybug), Parlatoria pergandii (root scale), Parlatoria ziziphi (black scale), Peregrinus maidis (maize delphicid), Philaenus spp. (leafhoppers), Phylloxera vitifoliae (vine phylloxera), Physokermes piceae (fir bud scale), Planococcus spp. (mealybugs), Pseudococcus spp. (mealybugs), Pseudococcus brevipes (pineapple powdery scale), Quadraspidiotus perniciosus (St. Joseph's aphid), Rhapalosiphum spp. (aphids), Rhapalosiphum maida (corn aphid), Rhapalosiphum padi (wild cherry aphid), Saissetia spp. (scale insects), Saissetia oleae (black scale), Schizaphis graminum (green aphid), Sitobion avenae (corn aphid), Sogatella furcifera (whitebacked leafhopper), Therioaphis spp. (aphids), Toumeyella spp. (scale insects), Toxoptera spp. (aphids), Trialeurodes spp. (whiteflies), Trialeurodes vaporariorum (greenhouse whitefly), Trialeurodes abutiloneus (banded-wing whitefly), Unaspis spp. Petition 870250102105, dated 07 / 11 / 2025, page 86 / 195 65 / 156 (mealybugs), Unaspis yanonensis (Yanon scale) and Zulia entreriana.
[0253] In yet another category, insect pests are of the order Lepidoptera, such as Achoea janata, Adoxophyes spp., Adoxophyes orana, Agrotis spp. (caterpillars), Agrotis ipsilon (black bollworm), Alabama argillacea (cotton bollworm), Amorbia cuneana, Ectomyelois ceratoniae, Amyelosis transitella (navel caterpillar), Anacamptodes defectaria, Anarsia lineatella (peach branch borer), Anomis sabulifera (jute looper), Anticarsia gemmatalis (velvet bean caterpillar), Archips argyrospila (fruit tree leaf rollers), Archips rosana (rose leaf rollers), Argyrotaenia spp. (tortricidal moths), Argyrotaenia citrana (orange tortrix), Autographa gamma, Bonagota cranaodes, Borbo cinnara (rice leaf bender), Bucculatrix thurberiella (cotton leaf borer), Caloptilia spp. (leaf miners), Capua reticulana, Carposina niponensis (peach moth), C. auricilius, Chilo spp., Chlumetia transversa (mango bud borer), Choristoneura rosaceana (oblique leaf roller), Chrysodeixis spp., Cnaphalocerus medinalis (grass leaf roller), Colias spp., Conpomorpha cramerella, Cossus (carpenter moth), Crambus spp. (lawn worms), Cydia funebrana (plum fruit moth), Cydia molesta (oriental fruit moth), Cydia nignicana (pea moth), Cydia pomonella (apple moth), Darna diducta, Diaphania spp. (stem borer), Diatraea spp. (stem borer), Diatraea saccharalis (sugarcane borer), Diatraea graniosella (southwestern corn borer), Earias spp. (cotton bollworms), Earias insulata (caterpillar. Petition 870250102105, dated 07 / 11 / 2025, p. 87 / 195 66 / 156 Egyptian), Earias vitella (northern rough caterpillar), Ecdytopopha aurantianum, Elasmopalpus lignosellus (lesser corn stem borer), Epiphysias postruttana (light brown apple moth), Ephestia spp. (flour moth), Ephestia cautella (almond moth), Ephestia elutella (tobacco moth), Ephestia kuehniella (Mediterranean flour moth), Epimeces spp., Epinotia aporema, Erionota thrax (banana moth), Eupoecilia ambiguella (grape moth), Euxoa auxiliaris (army caterpillar), Feltia spp. (cutaneous worms), Gortyna spp. (stem borers), Grapholita molesta (oriental moth), Hedylepta indicata (leafroller caterpillar), Helicoverpa spp. (noctuid moths), Helicoverpa armigera (cotton bollworm), Helicoverpa zea (corn caterpillar), Heliothis spp. (noctuid moths), Heliothis virescens (tobacco budworm), Hellula undalis (cabbage caterpillar), Indarbela spp.(root borers), Keiferia lycopersicella (tomato leafminer), Leucinodes orbonalis (eggplant borer), Leucoptera malifoliella, Lithocollectis spp., Lobesia botrana (grape moth), Loxagrotis spp. (noctuid moths), Loxagrotis albicosta (western bean weevil), Lymantria dispar (gypsy moth), Lyonetia clerkella (apple leaf miner), Mahasena corbetti (oil palm caterpillar), Malacosoma spp. (tent caterpillars), Mamestra brassicae (cabbage caterpillar), Maruca testulalis (bean pod borer), Metisa plana (sack caterpillar), Mythimna unipuncta (true fall armyworm), Neoleucinodes elegantelis (small tomato borer), Nymphula depunctalis (rice armyworm), Operophthera brumata (winter moth), Ostrinia. Petition 870250102105, dated 07 / 11 / 2025, page 88 / 195 67 / 156 nubilalis (European corn borer), Oxydia vesulia, Pandemis cerasana (common currant tortrix), Pandemis heparana (brown apple tortrix), Papilio demodocus, Pectinophora gossypiella (pink bollworm), Peridroma spp. (caterpillars), Peridroma saucia (variegated caterpillar), Perileucoptera coffeella (white coffee leafminer), Phthorimaea operculella (potato tuber moth), Phyllocnisitis citrella, Phyllonorycter spp. (leafminers), Pieris rapae (imported cabbage caterpillar), Plathypena scabra, Plodia interpunctella (Indian moth), Plutella xylostella (diamond moth), Polychrosis viteana (grape moth), Prays endocarpa, Prays oleae (olive moth), Pseudaletia spp. (noctuid moths), Pseudaletia unipunctata (caterpillar), Pseudoplusia includens (soybean looper), Rachiplusia nu, S. innotata, Scirpophaga incertulas, Sesamia spp.(stem borer), Sesamia inferens (pink rice stem borer), Sesamia nonagrioides, Setora nitens, Sitotroga cerealella (Angoumois grain moth), Sparganothis pilleriana, Spodoptera littoralis (cotton bollworm), Spodoptera spp. (fall armyworm), Spodoptera exigua (beetroot fall armyworm), Spodoptera fulperiperda (corn fall armyworm), Spodoptera oridania (southern fall armyworm), Synanthedon spp. (root borers), Thecla basilides, Thermisia gemmatalis, Tineola bisselliella (clothes moth), Trichoplusia ni (cabbage looper), Tuta absoluta, Yponomeuta spp., Zeuzera coffeae (red stem borer), Halyomorpha halys (stink bug), Eriococcus spp. (leopard moth). Petition 870250102105, dated 07 / 11 / 2025, page 89 / 195 68 / 156
[0254] In yet another category, insect pests are of the order Orthoptera, such as Anabrus simplex (cannibal crickets), Gryllotalpidae (mole crickets), Locusta migratoria, Melanoplus spp. (grasshoppers), Microcentrum retinerve (angular-winged katydid), Pterophylla spp. (katydids), Chistocerca gregaria, Scudderia furcata (forked-tailed katydid) and Valanga nigricorni.
[0255] In yet another category, the insect pests are of the order Thysanoptera, such as Frankliniella fusca (tobacco thrips), Frankliniella occidentalis (western flower thrips), Frankliniella shultzei, Frankliniella williamsi (corn thrips), Heliothrips haemorrhaidalis (greenhouse thrips), Riphiphorothrips cruentatus, Scirtothrips spp., Scirtothrips citri (citrus thrips), Scirtothrips dorsalis (yellow tea thrips), Taeniothrips rhopalantennalis, Selenothrips spp., Chaetanaphothrips spp. and Thrips spp..
[0256] In some embodiments, the insects include but are not limited to Spidermites, Halotydeus spp., Tetranychus urticae, Spodoptera littoralis, Spodoptera spp., Helicoverpa spp., Aphis spp., Myzus spp., Bemisia tabaci, Trialurodes vaporariorum, Tuta absoluta, Halyomorpha halys, Drosophila spp., Frankliniella spp., Aphis gossypii, Tetranichus spp., Lygus spp., Bactrocera dorsalis, B. tryoni, Ceratitis spp., Ceratitis capitata, Bactericera cockerelli, Nysius spp., Nilaparvata lugens, Ectomyelois ceratoniae, Amyelosis transitella, C. auricilius, Chilo spp., Cnaphalocerus medinalis, Cydia pomonella, S. innotata, Scirpophaga incertulas, Eriococcus spp., Ulonemia spp., Heliothrips haemorrhaidalis, Selenothrips spp. and Chaetanaphothrips spp. Petition 870250102105, dated 07 / 11 / 2025, p. 90 / 195 69 / 156
[0257] The weight ratio between Tau-fluvalinate and at least one crop protection compound II, as defined above, varies depending on several conditions such as the type of formulation, climatic conditions, the type of crop and the type of pests.
[0258] In one embodiment, the present invention provides a mixture combination comprising Tau-fluvalinate and one or more active compounds II, as mentioned above, wherein the application rates of the mixture according to the invention are from 1 g / ha to 1000 g / ha. In another embodiment, the application rate of the mixture according to the invention is from 500 g / ha to 1000 g / ha. In yet another embodiment, the application rate of the mixture according to the invention is from 1 g / ha to 500 g / ha.
[0259] In another embodiment, Tau-fluvalinate and crop protection chemical compound II, as defined above, may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures.
[0260] That is, each of Tau-fluvalinate and crop protection chemical compound II can be applied together or in succession. In one example, Tau-fluvalinate and crop protection chemical compound II are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, Tau-fluvalinate and crop protection chemical compound II are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another Petition 870250102105, dated 07 / 11 / 2025, page 91 / 195 70 / 156 For example, Tau-fluvalinate and crop protection chemical compound II are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0261] For example, taufluvalinate and gamma-cyhalothrin may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and gamma-cyhalothrin are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and gamma-cyhalothrin are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and gamma-cyhalothrin are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0262] For example, tau-fluvalinate and alpha-cypermethrin can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and alpha-cypermethrin are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and alpha-cypermethrin are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau Petition 870250102105, dated 07 / 11 / 2025, page 92 / 195 71 / 156 fluvalinate and Alpha-cypermethrin are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0263] For example, tau-fluvalinate and etofenprox can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and etofenprox are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and etofenprox are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and etofenprox are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0264] For example, taufluvalinate and spinosad can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and spinosad are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and spinosad are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and spinosad are formulated in Petition 870250102105, dated 07 / 11 / 2025, page 93 / 195 72 / 156 set, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0265] For example, tau-fluvalinate and flupiradifurone may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and flupiradifurone are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and flupiradifurone are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and flupiradifurone are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0266] For example, tau-fluvalinate and flupirimine may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and flupirimine are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and flupirimine are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and flupirimine are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration. Petition 870250102105, dated 07 / 11 / 2025, page 94 / 195 73 / 156
[0267] For example, tau-fluvalinate and triflumezopyrim can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and triflumezopyrim are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and triflumezopyrim are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and triflumezopyrim are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0268] For example, tau-fluvalinate and chlorfenapyr may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and chlorfenapyr are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and chlorfenapyr are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and chlorfenapyr are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0269] For example, tau-fluvalinate and brochlorfenapyr can be applied simultaneously, that is, together or Petition 870250102105, dated 07 / 11 / 2025, pages 95 / 195 74 / 156 separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and brochlorfenapyr are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and brochlorfenapyr are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and brochlorfenapyr are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0270] For example, tau-fluvalinate and tetrachloraniliprol may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and tetrachloraniliprol are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and tetrachloraniliprol are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and tetrachloraniliprol are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0271] For example, tau-fluvalinate and tetrachloraniliprol can be applied simultaneously, that is, together or separately, or in succession, not Petition 870250102105, dated 07 / 11 / 2025, pp. 96 / 195 75 / 156 having the sequence, in the case of separate application, generally no effect on the outcome of the control measures. In one example, taufluvalinate and thiotraniliprole are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and thiotraniliprole are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and thiotraniliprole are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0272] For example, tau-fluvalinate and Bensultape can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and Bensultape are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and Bensultape are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and Bensultape are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0273] For example, tau-fluvalinate and cartap hydrochloride can be applied simultaneously, that is, together or separately, or in succession, not having a sequence, in the case of separate application, generally Petition 870250102105, dated 07 / 11 / 2025, p. 97 / 195 76 / 156 any effect on the outcome of the control measures. In one example, tau-fluvalinate and cartap hydrochloride are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and cartap hydrochloride are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and cartap hydrochloride are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0274] For example, tau-fluvalinate and thiocyclam may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures.In one example, taufluvalinate and thiocyclam are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and thiocyclam are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and thiocyclam are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0275] For example, taufluvalinate and tissultap sodium may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau. Petition 870250102105, dated 07 / 11 / 2025, pp. 98 / 195 77 / 156 fluvalinate and Tissultape-sodium are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and Tissultape-sodium are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and Tissultape-sodium are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0276] For example, tau-fluvalinate and phenazaquin can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and phenazaquin are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and phenazaquin are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and phenazaquin are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0277] For example, taufluvalinate and phenazaquine can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and pyridaben are prepared separately, and the individual formulations are applied as is or Petition 870250102105, dated 07 / 11 / 2025, page 99 / 195 78 / 156 diluted to predetermined concentrations. In a further example, tau-fluvalinate and pyridaben are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and pyridaben are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0278] For example, tau-fluvalinate and pyridaben can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and pyrimidifen are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and pyrimidifen are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and pyrimidifen are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0279] For example, taufluvalinate and tebufenpyrad can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and tebufenpyrad are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and tebufenpyrad are prepared Petition 870250102105, dated 07 / 11 / 2025, pages 100 / 195 79 / 156 separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and tebufenpyrad are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0280] For example, tau-fluvalinate and cyepyrafene can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and cyepyrafene are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and cyepyrafene are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and cyepyrafene are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0281] For example, taufluvalinate and fluxamethamide can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and fluxamethamide are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and fluxamethamide are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another Petition 870250102105, dated 07 / 11 / 2025, page 101 / 195 80 / 156 For example, tau-fluvalinate and fluxamethamide are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0282] For example, taufluvalinate and isocycloseram can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and isocycloseram are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and isocycloseram are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and isocycloseram are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0283] For example, taufluvalinate and phenoxycarb may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and phenoxycarb are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and phenoxycarb are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and phenoxycarb are formulated in Petition 870250102105, dated 07 / 11 / 2025, page 102 / 195 81 / 156 set, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0284] For example, tau-fluvalinate and milbemectin may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and milbemectin are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and milbemectin are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and milbemectin are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0285] For example, tau-fluvalinate and lepimectin may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and lepimectin are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and lepimectin are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and lepimectin are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration. Petition 870250102105, dated 07 / 11 / 2025, page 103 / 195 82 / 156
[0286] For example, tau-fluvalinate and metaflumizone may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and metaflumizone are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and metaflumizone are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and metaflumizone are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0287] For example, tau-fluvalinate and diflubenzurone may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and diflubenzurone are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and diflubenzurone are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and diflubenzurone are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0288] For example, tau-fluvalinate and flufenoxurone can be applied simultaneously, that is, together or Petition 870250102105, dated 07 / 11 / 2025, page 104 / 195 83 / 156 separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and flufenoxurone are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and flufenoxurone are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and flufenoxurone are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0289] For example, tau-fluvalinate and lufenuron may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and lufenuron are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and lufenuron are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and lufenuron are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0290] For example, tau-fluvalinate and lufenurone can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on Petition 870250102105, dated 07 / 11 / 2025, page 105 / 195 84 / 156 result of control measures. In one example, taufluvalinate and teflubenzurone are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and teflubenzurone are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and teflubenzurone are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0291] For example, taufluvalinate and chlorfluazurone may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and chlorfluazurone are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and chlorfluazurone are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and chlorfluazurone are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0292] For example, taufluvalinate and pidoxamate can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and pidoxamate are prepared separately, and Petition 870250102105, dated 07 / 11 / 2025, page 106 / 195 85 / 156 The individual formulations are applied as is or diluted to predetermined concentrations. In one further example, tau-fluvalinate and pidoxamate are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and pidoxamate are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0293] For example, tau-fluvalinate and spirodiclofen can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and spirodiclofen are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and spirodiclofen are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and spirodiclofen are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0294] For example, taufluvalinate and spiromesifen can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and spiromesifen are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In one example Petition 870250102105, dated 07 / 11 / 2025, page 107 / 195 86 / 156 additionally, tau-fluvalinate and spiromesifen are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and spiromesifen are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0295] For example, tau-fluvalinate and Beauveria spp. may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and Beauveria spp. are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and Beauveria spp. are prepared separately, and the formulations are mixed when diluted to a predetermined concentration.In another example, tau-fluvalinate and Beauveria spp. are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0296] For example, tau-fluvalinate and Metarhizium spp. They can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and Metarhizium spp. are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and Metarhizium spp. are prepared separately, and the formulations are mixed when Petition 870250102105, dated 07 / 11 / 2025, page 108 / 195 87 / 156 diluted to a predetermined concentration. In another example, tau-fluvalinate and Metarhizium spp. are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0297] For example, tau-fluvalinate and Paecilomyces spp. may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and Paecilomyces spp. are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and Paecilomyces spp. are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and Paecilomyces spp.They are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0298] For example, tau-fluvalinate and GV of Cydia pomonella can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and GV of Cydia pomonella are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and GV of Cydia pomonella are prepared separately, and the formulations are mixed when diluted to a Petition 870250102105, dated 07 / 11 / 2025, page 109 / 195 88 / 156 predetermined concentration. In another example, taufluvalinate and GV of Cydia pomonella are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0299] For example, taufluvalinate and GV of Thaumatotibia leucotreta may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and GV of Thaumatotibia leucotreta are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and GV of Thaumatotibia leucotreta are prepared separately, and the formulations are mixed when diluted to a predetermined concentration.In another example, taufluvalinate and GV from Thaumatotibia leucotreta are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0300] For example, tau-fluvalinate and MNPV from Anticarsia gemmatalis may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and MNPV from Anticarsia gemmatalis are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and MNPV from Anticarsia gemmatalis are prepared separately, and the formulations are mixed when diluted to one. Petition 870250102105, dated 07 / 11 / 2025, page 110 / 195 89 / 156 predetermined concentration. In another example, taufluvalinate and MNPV from Anticarsia gemmatalis are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0301] For example, tau-fluvalinate and Helicoverpa armigera NPV can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and Helicoverpa armigera NPV are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and Helicoverpa armigera NPV are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and Helicoverpa armigera NPV are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0302] For example, taufluvalinate and flomethoquine may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and flomethoquine are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and flomethoquine are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another Petition 870250102105, dated 07 / 11 / 2025, page 111 / 195 90 / 156 For example, tau-fluvalinate and flomethoquine are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0303] For example, tau-fluvalinate and buprofezin may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and buprofezin are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and buprofezin are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and buprofezin are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0304] For example, taufluvalinate and cromofenozide can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and cromofenozide are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and cromofenozide are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and cromofenozide are formulated in Petition 870250102105, dated 07 / 11 / 2025, page 112 / 195 91 / 156 set, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0305] For example, taufluvalinate and halofenozide may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and halofenozide are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and halofenozide are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and halofenozide are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0306] For example, taufluvalinate and methoxyfenozide may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and methoxyfenozide are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and methoxyfenozide are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and methoxyfenozide are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration. Petition 870250102105, dated 07 / 11 / 2025, page 113 / 195 92 / 156
[0307] For example, tau-fluvalinate and tebufenozide may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and tebufenozide are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and tebufenozide are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and tebufenozide are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0308] For example, tau-fluvalinate and acequinocil can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and acequinocil are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and acequinocil are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and acequinocil are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0309] For example, tau-fluvalinate and fluacripirim can be applied simultaneously, that is, together or Petition 870250102105, dated 07 / 11 / 2025, page 114 / 195 93 / 156 separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and fluacripirim are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and fluacripirim are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and fluacripirim are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0310] For example, taufluvalinate and hydramethylnon may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and hydramethylnon are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and hydramethylnon are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and hydramethylnon are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0311] For example, tau-fluvalinate and Clitoria ternatea can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on Petition 870250102105, dated 07 / 11 / 2025, pages 115 / 195 94 / 156 result of control measures. In one example, taufluvalinate and Clitoria ternatea are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and Clitoria ternatea are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and Clitoria ternatea are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0312] For example, tau-fluvalinate and GS-omega / kappa HXTX-Hv1a peptide can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and GS-omega / kappa HXTX-Hv1a peptide are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and GS-omega / kappa HXTX-Hv1a peptide are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and GS-omega / kappa HXTX-Hv1a peptide are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0313] For example, tau-fluvalinate and acinonapyr can be applied simultaneously, that is, together or separately, or in succession, without the sequence, in Petition 870250102105, dated 07 / 11 / 2025, pp. 116 / 195 95 / 156 In the case of separate application, generally any effect on the outcome of the control measures. In one example, taufluvalinate and acinonapyr are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and acinonapyr are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and acinonapyr are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0314] For example, N-octyl bicycloheptene tau-fluvalinate and dicarboximide (MGK-264) can be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, N-octyl bicycloheptene tau-fluvalinate and dicarboximide (MGK-264) are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, N-octyl bicycloheptene tau-fluvalinate and dicarboximide (MGK-264) are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, N-octyl bicycloheptene tau-fluvalinate and dicarboximide (MGK-264) are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0315] For example, tau-fluvalinate and Piprotal can be applied simultaneously, that is, together or Petition 870250102105, dated 07 / 11 / 2025, p. 117 / 195 96 / 156 separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and Piprotal are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and Piprotal are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and Piprotal are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0316] For example, tau-fluvalinate and propyl isosome may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures.In one example, taufluvalinate and propyl isosome are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and propyl isosome are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In yet another example, taufluvalinate and propyl isosome are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0317] For example, tau-fluvalinate and Sesamex can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on Petition 870250102105, dated 07 / 11 / 2025, pp. 118 / 195 97 / 156 result of control measures. In one example, taufluvalinate and sesamex are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and sesamex are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and sesamex are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0318] For example, tau-fluvalinate and sesamolin may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and sesamolin are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and sesamolin are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and sesamolin are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0319] For example, taufluvalinate and sulfoxide can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and sulfoxide are prepared separately, and the Petition 870250102105, dated 07 / 11 / 2025, pp. 119 / 195 98 / 156 Individual formulations are applied as is or diluted to predetermined concentrations. In one further example, tau-fluvalinate and sulfoxide are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and sulfoxide are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0320] For example, tau-fluvalinate and pidiflumethophene may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and pidiflumethophene are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and pidiflumethophene are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and pidiflumethophene are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0321] For example, taufluvalinate and fluazinam can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and fluazinam are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In one example Petition 870250102105, dated 07 / 11 / 2025, pages 120 / 195 99 / 156 additionally, tau-fluvalinate and fluazinam are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and fluazinam are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0322] For example, tau-fluvalinate and fluxapyroxad may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and fluxapyroxad are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and fluxapyroxad are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and fluxapyroxad are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0323] For example, taufluvalinate and difenoconazole can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and difenoconazole are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and difenoconazole are prepared separately, and the formulations are mixed when Petition 870250102105, dated 07 / 11 / 2025, pp. 121 / 195 100 / 156 diluted to a predetermined concentration. In another example, tau-fluvalinate and difenoconazole are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0324] For example, tau-fluvalinate and tebuconazole can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and tebuconazole are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and tebuconazole are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and tebuconazole are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0325] For example, tau-fluvalinate and fludioxonil can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and fludioxonil are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and fludioxonil are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and fludioxonil are formulated in Petition 870250102105, dated 07 / 11 / 2025, page 122 / 195 101 / 156 set, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0326] For example, taufluvalinate and azoxystrobin can be applied simultaneously, either together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and azoxystrobin are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and azoxystrobin are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and azoxystrobin are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0327] For example, tau-fluvalinate and mancozeb can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and mancozeb are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and mancozeb are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and mancozeb are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration. Petition 870250102105, dated 07 / 11 / 2025, pp. 123 / 195 102 / 156
[0328] For example, tau-fluvalinate and cycloxapride may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and cycloxapride are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and cycloxapride are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and cycloxapride are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0329] For example, tau-fluvalinate and guadipyr can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and guadipyr are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and guadipyr are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and guadipyr are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0330] For example, tau-fluvalinate and imidaclotilde can be applied simultaneously, that is, together or Petition 870250102105, dated 07 / 11 / 2025, pp. 124 / 195 103 / 156 separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and imidaclotz are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and imidaclotz are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and imidaclotz are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0331] For example, tau-fluvalinate and cyflumethophene may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and cyflumethophene are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and cyflumethophene are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and cyflumethophene are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0332] For example, tau-fluvalinate and Sila-Ciflumethophene can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on Petition 870250102105, dated 07 / 11 / 2025, pages 125 / 195 104 / 156 result of control measures. In one example, taufluvalinate and Sila-Ciflumethophene are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and Sila-Ciflumethophene are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and Sila-Ciflumethophene are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0333] For example, tau-fluvalinate and ciproflanilide may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and ciproflanilide are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and ciproflanilide are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and ciproflanilide are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0334] For example, tau-fluvalinate and dichloromezotiaz can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau Petition 870250102105, dated 07 / 11 / 2025, pp. 126 / 195 105 / 156 fluvalinate and dichloromezotiaz are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and dichloromezotiaz are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and dichloromezotiaz are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0335] For example, tau-fluvalinate and fenmezoditiaz can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and fenmezoditiaz are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and fenmezoditiaz are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and fenmezoditiaz are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0336] For example, taufluvalinate and dimpropiridaz can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and dimpropiridaz are prepared separately, and the individual formulations are applied as is or Petition 870250102105, dated 07 / 11 / 2025, page 127 / 195 106 / 156 diluted to predetermined concentrations. In a further example, tau-fluvalinate and dimpropiridaz are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and dimpropiridaz are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0337] For example, tau-fluvalinate and ticlopyrazflor may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and ticlopyrazflor are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and ticlopyrazflor are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and ticlopyrazflor are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0338] For example, tau-fluvalinate and fluchlordiniliprole can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and fluchlordiniliprole are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and Petition 870250102105, dated 07 / 11 / 2025, page 128 / 195 107 / 156 Fluchlordiniliprole are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and fluchlordiniliprole are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0339] For example, tau-fluvalinate and fluazaindolizine may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and fluazaindolizine are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and fluazaindolizine are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and fluazaindolizine are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0340] For example, taufluvalinate and flufiprol can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and flufiprol are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and flufiprol are prepared separately, and the formulations are mixed when Petition 870250102105, dated 07 / 11 / 2025, page 129 / 195 108 / 156 diluted to a predetermined concentration. In another example, tau-fluvalinate and flufiprol are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0341] For example, tau-fluvalinate and nicofluprol may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and nicofluprol are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and nicofluprol are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and nicofluprol are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0342] For example, taufluvalinate and piriprol can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and piriprol are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and piriprol are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and piriprol are formulated in Petition 870250102105, dated 07 / 11 / 2025, pp. 130 / 195 109 / 156 set, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0343] For example, tau-fluvalinate and fluhexaphone can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and fluhexaphone are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and fluhexaphone are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and fluhexaphone are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0344] For example, tau-fluvalinate and bistriflurone can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and bistriflurone are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and bistriflurone are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and bistriflurone are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration. Petition 870250102105, dated 07 / 11 / 2025, page 131 / 195 110 / 156
[0345] For example, tau-fluvalinate and trifluenfuronate can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and trifluenfuronate are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and trifluenfuronate are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and trifluenfuronate are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0346] For example, tau-fluvalinate and lotilaner can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and lotilaner are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and lotilaner are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and lotilaner are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0347] For example, tau-fluvalinate and indazapyroxamet can be applied simultaneously, that is, together or Petition 870250102105, dated 07 / 11 / 2025, page 132 / 195 111 / 156 separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and indazapyroxamet are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and indazapyroxamet are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and indazapyroxamet are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0348] For example, taufluvalinate and one or more mineral oils may be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures.In one example, tau-fluvalinate and one or more mineral oils are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and one or more mineral oils are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and one or more mineral oils are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0349] For example, tau-fluvalinate and paraffinic oils may be applied simultaneously, i.e., together or separately, or in succession, not having the sequence, no. Petition 870250102105, dated 07 / 11 / 2025, page 133 / 195 112 / 156 In the case of separate application, generally any effect on the outcome of the control measures. In one example, taufluvalinate and paraffin oils are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and paraffin oils are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and paraffin oils are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0350] For example, tau-fluvalinate and garlic extract can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and garlic extract are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and garlic extract are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and garlic extract are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0351] For example, tau-fluvalinate and bitterberry extract can be applied simultaneously, that is, together or separately, or in succession, not having a sequence, in the case of separate application, generally Petition 870250102105, dated 07 / 11 / 2025, page 134 / 195 113 / 156 any effect on the outcome of the control measures. In one example, taufluvalinate and bitterberry extract are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and bitterberry extract are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and bitterberry extract are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0352] For example, taufluvalinate and tea tree oil can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and tea tree oil are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and tea tree oil are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and tea tree oil are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0353] For example, tau-fluvalinate and clove oil can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on Petition 870250102105, dated 07 / 11 / 2025, pp. 135 / 195 114 / 156 result of control measures. In one example, taufluvalinate and clove oil are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and clove oil are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and clove oil are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0354] For example, taufluvalinate and citronella oil may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the result of the control measures.In one example, taufluvalinate and citronella oil are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, taufluvalinate and citronella oil are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and citronella oil are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0355] For example, tau-fluvalinate and rose oil can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau Petition 870250102105, dated 07 / 11 / 2025, page 136 / 195 115 / 156 fluvalinate and rose oil are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and rose oil are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and rose oil are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0356] For example, tau-fluvalinate and palmarosa oil may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and palmarosa oil are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations.In one further example, taufluvalinate and palmarosa oil are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, taufluvalinate and palmarosa oil are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0357] For example, taufluvalinate and geraniol can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and geraniol are prepared separately, and the Petition 870250102105, dated 07 / 11 / 2025, page 137 / 195 116 / 156 Individual formulations are applied as is or diluted to predetermined concentrations. In a further example, tau-fluvalinate and geraniol are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and geraniol are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0358] For example, tau-fluvalinate and thymol may be applied simultaneously, i.e., together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, tau-fluvalinate and thymol are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations.In one further example, tau-fluvalinate and thymol are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and thymol are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0359] For example, taufluvalinate and citronella can be applied simultaneously, that is, together or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and citronella are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations. In one example Petition 870250102105, dated 07 / 11 / 2025, page 138 / 195 117 / 156 additionally, tau-fluvalinate and citronella are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and citronella are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0360] For example, taufluvalinate and one or more agrochemically acceptable additives selected from a group comprising diatomaceous earth, amorphous silica, hydroxypropyl methylcellulose, kaolin (calcined), polydimethylsiloxane and potassium salts of fatty acids may be applied simultaneously, i.e., jointly or separately, or in succession, the sequence, in the case of separate application, generally having no effect on the outcome of the control measures. In one example, taufluvalinate and one or more agrochemically acceptable additives selected from a group comprising diatomaceous earth, amorphous silica, hydroxypropyl methylcellulose, kaolin (calcined), polydimethylsiloxane and potassium salts of fatty acids are prepared separately, and the individual formulations are applied as is or diluted to predetermined concentrations.In a further example, tau-fluvalinate and one or more agrochemically acceptable additives selected from a group comprising diatomaceous earth, amorphous silica, hydroxypropyl methylcellulose, kaolin (calcined), polydimethylsiloxane, and potassium salts of fatty acids are prepared separately, and the formulations are mixed when diluted to a predetermined concentration. In another example, tau-fluvalinate and one or more additives... Petition 870250102105, dated 07 / 11 / 2025, page 139 / 195 118 / 156 agrochemically acceptable ingredients selected from a group comprising Diatomaceous Earth, Amorphous Silica, Hydroxypropylmethylcellulose, Kaolin (calcined), Polydimethylsiloxane and Potassium Salts of Fatty Acids are formulated together, and the formulation is applied as is, or the formulation is diluted to a predetermined concentration.
[0361] In some embodiments, a quantity of taufluvalinate and a quantity of a synthetic pyrethroid when applied together are more effective than when taufluvalinate, in the same quantity, and the synthetic pyrethroid, in the same quantity, are applied separately.
[0362] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a synthetic pyrethroid in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0363] In some modalities, a quantity of taufluvalinate and a quantity of a competitive nicotinic acetylcholine receptor modulator (nAChR) when applied together are more effective than when taufluvalinate, in the same quantity, and the competitive nicotinic acetylcholine receptor modulator (nAChR), in the same quantity, are applied separately.
[0364] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a competitive modulator of the nicotinic acetylcholine receptor (nAChR) in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against infection by Petition 870250102105, dated 07 / 11 / 2025, pp. 140 / 195 119 / 156 insects than if (i) the same quantity and (ii) the same quantity were applied separately.
[0365] In some embodiments, a quantity of taufluvalinate and a quantity of an oxidative phosphorylation uncoupler by interrupting the proton gradient, when applied together, are more effective than when taufluvalinate, in the same quantity, and the oxidative phosphorylation uncoupler by interrupting the proton gradient, in the same quantity, are applied separately.
[0366] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an oxidative phosphorylation uncoupler through proton gradient disruption in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately.
[0367] In some embodiments, a quantity of taufluvalinate and a quantity of a ryanodine receptor modulator when applied together are more effective than when taufluvalinate, in the same quantity, and the ryanodine receptor modulator, in the same quantity, are applied separately.
[0368] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a ryanodine receptor modulator in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) in the same Petition 870250102105, dated 07 / 11 / 2025, p. 141 / 195 120 / 156 quantity and (ii) in the same quantity are applied separately.
[0369] In some embodiments, an amount of taufluvalinate and an amount of a nicotinic acetylcholine receptor channel blocker when applied together are more effective than when taufluvalinate, in the same amount, and the nicotinic acetylcholine receptor channel blocker, in the same amount, are applied separately.
[0370] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an acetylcholine nicotinic receptor channel blocker in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0371] In some embodiments, a quantity of taufluvalinate and a quantity of a mitochondrial electron transport inhibitor (METI) when applied together are more effective than when taufluvalinate, in the same quantity, and the mitochondrial electron transport inhibitor (METI), in the same quantity, are applied separately.
[0372] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a mitochondrial complex electron transport inhibitor (METI) in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately. Petition 870250102105, dated 07 / 11 / 2025, page 142 / 195 121 / 156
[0373] In some embodiments, a quantity of taufluvalinate and a quantity of a meta-diamide insecticide when applied together are more effective than when taufluvalinate, in the same quantity, and a meta-diamide insecticide, in the same quantity, are applied separately.
[0374] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a metadiamide insecticide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0375] In some embodiments, an amount of taufluvalinate and an amount of a broad-spectrum insect growth regulator when applied together are more effective than when taufluvalinate, in the same amount, and a broad-spectrum insect growth regulator, in the same amount, are applied separately.
[0376] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a broad-spectrum insect growth regulator in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0377] In some embodiments, a quantity of taufluvalinate and a quantity of an allosteric modulator of the glutamate-gated chloride channel (GluCl) when applied together are more effective than when tau Petition 870250102105, dated 07 / 11 / 2025, pp. 143 / 195 122 / 156 fluvalinate, in the same quantity, and the allosteric modulator of the glutamate-gated chloride channel (GluCl), in the same quantity, are applied separately.
[0378] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an allosteric modulator of the glutamate-gated chloride channel (GluCl) in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0379] In some embodiments, an amount of taufluvalinate and an amount of a voltage-dependent sodium channel blocker when applied together are more effective than when taufluvalinate, in the same amount, and the voltage-dependent sodium channel blocker, in the same amount, are applied separately.
[0380] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a voltage-dependent sodium channel blocker in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0381] In some embodiments, a quantity of taufluvalinate and a quantity of a chitin biosynthesis inhibitor affecting CHS1, when applied together, are more effective than when taufluvalinate, in the same quantity, and the chitin biosynthesis inhibitor affecting CHS1, in the same quantity, are applied separately. Petition 870250102105, dated 07 / 11 / 2025, pp. 144 / 195 123 / 156
[0382] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a chitin biosynthesis inhibitor affecting CHS1 in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately.
[0383] In some embodiments, a quantity of taufluvalinate and a quantity of an acetyl CoA carboxylase inhibitor when applied together are more effective than when taufluvalinate, in the same quantity, and the acetyl CoA carboxylase inhibitor, in the same quantity, are applied separately.
[0384] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an acetyl CoA carboxylase inhibitor in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately.
[0385] In some embodiments, a quantity of taufluvalinate and a quantity of an entomopathogenic fungal agent when applied together are more effective than when taufluvalinate, in the same quantity, and the entomopathogenic fungal agent, in the same quantity, are applied separately.
[0386] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an entomopathogenic fungal agent in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant. Petition 870250102105, dated 07 / 11 / 2025, pages 145 / 195 124 / 156 or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0387] In some embodiments, a quantity of taufluvalinate and a quantity of Granulovirus when applied together are more effective than when taufluvalinate, in the same quantity, and Granulovirus, in the same quantity, are applied separately.
[0388] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of Granulovirus in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately.
[0389] In some embodiments, a quantity of taufluvalinate and a quantity of a nucleopolyhedrosis virus when applied together are more effective than when taufluvalinate, in the same quantity, and the nucleopolyhedrosis virus, in the same quantity, are applied separately.
[0390] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a nucleopolyhedrosis virus in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately.
[0391] In some modalities, a quantity of taufluvalinate and a quantity of an Inhibitor of mitochondrial complex III electron transport - local Qi are applied Petition 870250102105, dated 07 / 11 / 2025, pages 146 / 195 125 / 156 together are more effective than when tau-fluvalinate, in the same quantity, and an inhibitor of mitochondrial complex III electron transport - Qi site, in the same quantity, are applied separately.
[0392] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a Mitochondrial Complex III electron transport inhibitor - Qi site in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately.
[0393] In some embodiments, an amount of taufluvalinate and an amount of a chitin biosynthesis inhibitor (type 1) when applied together are more effective than when taufluvalinate, in the same amount, and the chitin biosynthesis inhibitor (type 1), in the same amount, are applied separately.
[0394] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a chitin biosynthesis inhibitor (type 1) in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately.
[0395] In some embodiments, an amount of taufluvalinate and an amount of an ecdysone receptor agonist when applied together are more effective than when taufluvalinate, in the same amount, and an ecdysone receptor agonist, in the same amount, are applied separately. Petition 870250102105, dated 07 / 11 / 2025, pp. 147 / 195 126 / 156
[0396] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an ecdysone receptor agonist in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0397] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an ecdysone receptor agonist in a ratio of 1:50 to 50:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0398] In some specific embodiments, (i) the amount of tau-fluvalinate and (ii) an amount of methoxyfenozide in a ratio of 1:50 to 50:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0399] In a more specific embodiment, (i) the amount of tau-fluvalinate and (ii) an amount of methoxyfenozide in a ratio of 1:1 to 5:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0400] In some embodiments, an amount of taufluvalinate and an amount of a transport inhibitor Petition 870250102105, dated 07 / 11 / 2025, pp. 148 / 195 127 / 156 electron transport inhibitors from mitochondrial complex III (Qo site) when applied together are more effective than when tau-fluvalinate, in the same quantity, and an inhibitor of mitochondrial complex III electron transport (Qo site), in the same quantity, are applied separately.
[0401] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an Inhibitor of mitochondrial complex II electron transport (Qo site) in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately.
[0402] In some embodiments, a quantity of taufluvalinate and a quantity of a cyclotide insecticide and repellent when applied together are more effective than when taufluvalinate, in the same quantity, and a cyclotide insecticide and repellent, in the same quantity, are applied separately.
[0403] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a cyclotide insecticide and repellent in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0404] In some embodiments, a quantity of taufluvalinate and a quantity of an allosteric modulator of the nicotinic acetylcholine receptor (nAChR) (site II) when applied together are more effective than when taufluvalinate, in the same quantity, and the allosteric modulator are used together. Petition 870250102105, dated 07 / 11 / 2025, pp. 149 / 195 128 / 156 of the nicotinic acetylcholine receptor (nAChR) (site II), in the same quantity, are applied separately.
[0405] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an allosteric modulator of the nicotinic acetylcholine receptor (nAChR) (site II) in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0406] In some embodiments, an amount of taufluvalinate and an amount of a calcium-activated potassium channel modulator (KCa2) when applied together are more effective than when taufluvalinate, in the same amount, and the calcium-activated potassium channel modulator (KCa2), in the same amount, are applied separately.
[0407] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a calcium-activated potassium channel modulator (KCa2) in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) the same amount and (ii) the same amount are applied separately.
[0408] In some embodiments, a quantity of taufluvalinate and a quantity of a synergistic insecticidal agent when applied together are more effective than when taufluvalinate, in the same quantity, and a synergistic insecticidal agent, in the same quantity, are applied separately. Petition 870250102105, dated 07 / 11 / 2025, pages 150 / 195 129 / 156
[0409] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a synergistic insecticidal agent in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0410] In some embodiments, a quantity of taufluvalinate and a quantity of a Fungicide when applied together are more effective than when taufluvalinate, in the same quantity, and the Fungicide, in the same quantity, are applied separately.
[0411] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a Fungicide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0412] In some embodiments, a quantity of taufluvalinate and a quantity of a neonicotinoid insecticide when applied together are more effective than when taufluvalinate, in the same quantity, and a neonicotinoid insecticide, in the same quantity, are applied separately.
[0413] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a neonicotinoid insecticide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) in the same Petition 870250102105, dated 07 / 11 / 2025, pages 151 / 195 130 / 156 quantity and (ii) in the same quantity are applied separately.
[0414] In some embodiments, a quantity of taufluvalinate and a quantity of an acaricide, when applied together, are more effective than when taufluvalinate, in the same quantity, and the acaricide, in the same quantity, are applied separately.
[0415] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an acaricide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0416] In some embodiments, a quantity of taufluvalinate and a quantity of a diamide insecticide when applied together are more effective than when taufluvalinate, in the same quantity, and a diamide insecticide, in the same quantity, are applied separately.
[0417] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a diamide insecticide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0418] In some embodiments, a quantity of taufluvalinate and a quantity of a mesoionic insecticide when applied together are more effective than when taufluvalinate, in the same quantity, and the mesoionic insecticide, in the same quantity, are applied separately. Petition 870250102105, dated 07 / 11 / 2025, pages 152 / 195 131 / 156
[0419] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a mesoionic insecticide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0420] In some embodiments, a quantity of taufluvalinate and a quantity of a pyrazole carboxamide insecticide when applied together are more effective than when taufluvalinate, in the same quantity, and a pyrazole carboxamide insecticide, in the same quantity, are applied separately.
[0421] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a pyrazole carboxamide insecticide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0422] In some embodiments, an amount of taufluvalinate and an amount of a sulfonamide nematicide when applied together are more effective than when taufluvalinate, in the same amount, and sulfonamide nematicide, in the same amount, are applied separately.
[0423] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a sulfonamide nematicide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) in the same Petition 870250102105, dated 07 / 11 / 2025, pages 153 / 195 132 / 156 quantity and (ii) in the same quantity are applied separately.
[0424] In some embodiments, a quantity of taufluvalinate and a quantity of a phenylpyrazole insecticide when applied together are more effective than when taufluvalinate, in the same quantity, and the phenylpyrazole insecticide, in the same quantity, are applied separately.
[0425] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a phenylpyrazole insecticide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0426] In some embodiments, a quantity of taufluvalinate and a quantity of a fluorine-containing insecticide when applied together are more effective than when taufluvalinate, in the same quantity, and a fluorine-containing insecticide, in the same quantity, are applied separately.
[0427] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a fluorine-containing insecticide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0428] In some embodiments, a quantity of taufluvalinate and a quantity of a Parasiticide of Petition 870250102105, dated 07 / 11 / 2025, pages 154 / 195 133 / 156 isoxazoline, when applied together, is more effective than when tau-fluvalinate, in the same quantity, and the isoxazoline parasiticide, in the same quantity, are applied separately.
[0429] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an isoxazoline parasiticide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0430] In some embodiments, a quantity of taufluvalinate and a quantity of an indazole insecticide when applied together are more effective than when taufluvalinate, in the same quantity, and the indazole insecticide, in the same quantity, are applied separately.
[0431] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of an indazole insecticide in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0432] In some embodiments, a quantity of taufluvalinate and a quantity of one or more mineral oils when applied together are more effective than when taufluvalinate, in the same quantity, and one or more mineral oils, in the same quantity, are applied separately.
[0433] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of one or more mineral oils in a ratio of 1:100 to 100:1, if applied in Petition 870250102105, dated 07 / 11 / 2025, pp. 155 / 195 134 / 156 together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount were applied separately.
[0434] In some embodiments, an amount of taufluvalinate and an amount of a plant extract when applied together are more effective than when taufluvalinate, in the same amount, and the plant extract, in the same amount, are applied separately.
[0435] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a plant extract in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0436] In some embodiments, a quantity of taufluvalinate and a quantity of a repellent when applied together are more effective than when taufluvalinate, in the same quantity, and the repellent, in the same quantity, are applied separately.
[0437] In some embodiments, (i) the amount of taufluvalinate and (ii) an amount of a repellent in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infestation than if (i) the same amount and (ii) the same amount are applied separately.
[0438] In some embodiments, a quantity of taufluvalinate and a quantity of one or more agrochemically acceptable additives when applied together are more effective than when tau-fluvalinate, in the same Petition 870250102105, dated 07 / 11 / 2025, pp. 156 / 195 135 / 156 quantity, and one or more agrochemically acceptable additives, in the same quantity, are applied separately.
[0439] In some embodiments, (i) the quantity of taufluvalinate and (ii) a quantity of one or more agrochemically acceptable additives in a ratio of 1:100 to 100:1, if applied together, are more effective in treating a plant or soil against insect infection than if (i) in the same quantity and (ii) in the same quantity are applied separately.
[0440] In a further embodiment, the active compound mixture combination of the invention comprising: (i) tau-fluvalinate; and (ii) at least one crop protection chemical compound II, as defined above, is synergistically effective in controlling pests compared to when compound (i) in the same amount and compound (ii) in the same amount are applied separately, after several hours to several days of application.
[0441] In one embodiment, the active compound mixture combination of the invention comprising: (i) taufluvalinate; and (ii) at least one crop protection chemical compound II, as defined above, is synergistically effective in controlling pests compared to when compound (i) in the same amount and compound (ii) in the same amount are applied separately, after 48 hours of application.
[0442] In one embodiment, the active compound mixture combination of the invention comprising: (i) taufluvalinate; and (ii) at least one crop protection chemical compound II, as defined above, is synergistically effective in controlling pests compared to when the Petition 870250102105, dated 07 / 11 / 2025, pages 157 / 195 136 / 156 compound (i) in the same quantity and compound (ii) in the same quantity are applied separately, after 72 hours of application.
[0443] In one embodiment, the active compound mixture combination of the invention comprising: (i) taufluvalinate; and (ii) at least one crop protection chemical compound II, as defined above, is synergistically effective in controlling pests compared to when compound (i) in the same amount and compound (ii) in the same amount are applied separately, after 1 day of applications.
[0444] In one embodiment, the active compound mixture combination of the invention comprising: (i) taufluvalinate; and (ii) at least one crop protection chemical compound II, as defined above, is synergistically effective in controlling pests compared to when compound (i) in the same amount and compound (ii) in the same amount are applied separately, after 2 days of applications.
[0445] In one embodiment, the active compound mixture combination of the invention comprising: (i) taufluvalinate; and (ii) at least one crop protection chemical compound II, as defined above, is synergistically effective in controlling pests compared to when compound (i) in the same amount, and compound (ii) in the same amount, is applied alone, after 4 days of applications.
[0446] In one embodiment, the active compound mixture combination of the invention comprising: (i) taufluvalinate; and (ii) at least one chemical compound II for Petition 870250102105, dated 07 / 11 / 2025, pages 158 / 195 137 / 156 crop protection, as defined above, is synergistically effective in controlling pests compared to when compound (i) in the same quantity, and compound (ii) in the same quantity, are applied separately, after 6 days of applications.
[0447] In one embodiment, the active compound mixture combination of the invention comprising: (i) taufluvalinate; and (ii) at least one crop protection chemical compound II, as defined above, is synergistically effective in controlling pests compared to when compound (i) in the same amount and compound (ii) in the same amount are applied separately, after 7 days of applications.
[0448] In yet another embodiment, the synergistic composition may be applied in various mixtures or combinations of Tau-fluvalinate and a crop protection chemical compound II, as defined above, for example in a single ready-to-use form, or in a combined spray mixture composed from separate formulations of single active ingredients, such as a tank-mix form.
[0449] In yet another embodiment, the composition is applied in the form of a ready-to-use formulation comprising Tau-fluvalinate and a crop protection chemical compound. This formulation may be obtained by combining the active ingredients in an effective quantity with an agriculturally acceptable carrier, a surfactant or other application enhancer commonly used in formulation technology. Petition 870250102105, dated 07 / 11 / 2025, pages 159 / 195 138 / 156
[0450] According to one embodiment, the composition comprises at least one additional component selected from the group of surfactants, solid diluents and liquid diluents. Such compositions may be formulated using agriculturally acceptable carriers, surfactants or other application enhancers commonly employed in formulation technology and formulation techniques known in the art.
[0451] Examples of suitable solid carriers potentially useful in the present compositions include but are not limited to mineral earths such as silica gel, silicates, talc, kaolin, sericite, talc clay, limestone, bentonite, lime, chalk, fuste, mirabilite, loess, clay, dolomite, zeolite, diatomaceous earth, calcium carbonate, calcium sulfate, magnesium sulfate, magnesium oxide, sodium carbonate and bicarbonate and sodium sulfate; crushed synthetic materials; fertilizers such as ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas and products of vegetable origin such as cereal flour, tree bark flour, wood flour and walnut shell flour; cellulose powders; and other solid carriers.
[0452] Examples of suitable liquid carriers potentially useful in the present compositions include, but are not limited to, water; aromatic hydrocarbons such as alkylbenzenes and alkylnaphthalenes; alcohols such as cyclohexanol and decanol; ethylene glycol; polypropylene glycol; dipropylene glycol; N,N-dimethylformamide; dimethyl sulfoxide; dimethylacetamide; N-alkylpyrrolidones such as N-methyl-2-pyrrolidone; paraffins; various oils such as olive oil, Petition 870250102105, dated 07 / 11 / 2025, pages 160 / 195 139 / 156 castor oil, linseed oil, tung oil, sesame oil, corn, peanut oil, cottonseed oil, soybean oil, rapeseed oil or coconut oil; fatty acid esters; ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone; and similar products.
[0453] The present composition can be used or prepared in any conventional form, for example, as wettable powders (WP), emulsion concentrates (EC), microemulsion concentrates (MEC), water-soluble powders (SP), water-soluble concentrates (SL), suspoemulsions (SE), oil dispersions (OD), concentrated emulsions (BW) such as oil-in-water and water-in-oil emulsions, sprayable solutions or emulsions, capsule suspensions (CS), suspension concentrates (SC), suspension concentrates, powders (DP), oil-miscible solutions (OL), seed coating products, granules (GR) in the form of microgranules, spray granules, coated granules and absorption granules, granules for soil application or diffusion, water-soluble granules (SG), water-dispersible granules (WDG), ULV formulations, microcapsules or waxes. These types of individual formulations are known in the art.
[0454] Examples of suitable surfactants include, but are not limited to, nonionic, anionic, cationic and ampholytic types such as alkoxylated fatty alcohols, ethoxylated polysorbate (e.g., Tween 20), ethoxylated castor oil, lignin sulfonates, fatty acid sulfonates (e.g., lauryl sulfonate), phosphate esters such as alcohol alkoxylate phosphate esters, alkylphenol alkoxylate phosphate esters and styrylphenol ethoxylate phosphate esters, condensates of Petition 870250102105, dated 07 / 11 / 2025, pages 161 / 195 140 / 156 Naphthalene sulfonate and naphthalene derivatives with formaldehyde, naphthalene or naphthalenesulfonic acid condensates with phenol and formaldehyde, alkylaryl sulfonates, ethoxylated alkylphenols and arylphenols, polyalkylene glycols, sorbitol esters, alkali metal, sodium salts of lignosulfonates, tristyrylphenol ethoxylate phosphate esters, aliphatic alcohol ethoxylates, alkylphenol ethoxylates, ethylene oxide / propylene oxide block copolymers, graft copolymers and polyvinyl alcohol-vinyl acetate copolymers. Other surfactants known in the art may be used as desired.
[0455] Other ingredients, such as wetting agents, antifoaming agents, adhesives, neutralizers, thickeners, binders, sequestrants, fertilizers, biocides, stabilizers, buffers or antifreeze agents, may also be added to the present compositions in order to increase the stability, density and viscosity of the compositions described.
[0456] Aqueous dosage forms can be prepared from emulsion concentrates, suspensions, pastes, wettable powders or water-dispersible granules by adding water. To prepare emulsions, pastes or oil dispersions, the components of the compositions, either as such or dissolved in an oil or solvent, can be homogenized in water by means of a wetting agent, adhesive agent, dispersant or emulsifier. Alternatively, it is also possible to prepare concentrates comprising an active ingredient, wetting agent, adhesive agent, Petition 870250102105, dated 07 / 11 / 2025, pages 162 / 195 141 / 156 dispersant or emulsifier and, if desired, a solvent or oil, which are suitable for dilution with water.
[0457] In one embodiment, the amount of the active ingredient mixture in the composition is about 0.1-99% by weight, about 0.1-95% by weight, or about 0.1-90% by weight, based on the total weight of the composition. In another embodiment, the amount of the active ingredient mixture in the composition is about 1-70% by weight, based on the total weight of the composition. In yet another embodiment, the amount of the active ingredient mixture in the composition is about 150% by weight, based on the total weight of the composition. In yet another embodiment, the amount of the active ingredient mixture in the composition is about 1-40% by weight, based on the total weight of the composition. In yet another embodiment, the amount of the active ingredient mixture in the composition is about 1-30% by weight, based on the total weight of the composition. In yet another embodiment, the amount of the active ingredient mixture in the composition is about 120% by weight, based on the total weight of the composition.In yet another option, the amount of the active ingredient mixture in the composition is approximately 1-10% by weight, based on the total weight of the composition. The remaining components of the formulation are, for example, the carrier and additives.
[0458] In one embodiment, the amount of the active ingredient mixture in the composition is from about 0.1%, 0.5%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5% to about 90%, 93%, 95%, 98%, 99% based on the total weight of the composition.
[0459] In another embodiment, the present invention provides a case comprising a synergistic pesticide composition as described herein or components thereof. Such Petition 870250102105, dated 07 / 11 / 2025, pages 163 / 195 142 / 156 cases may comprise, in addition to the active components mentioned above, one or more additional active and / or inactive ingredients, either within the provided pesticide composition or separately.
[0460] As noted above, the compositions, cases, and methods described here exhibit a synergistic effect. A synergistic effect exists whenever the action of a combination of active components is greater than the sum of the action of each component individually. Therefore, a synergistically effective amount (or an effective amount of a synergistic composition or combination) is an amount that exhibits greater pesticidal activity than the sum of the activities of the individual components. METHOD OF USE
[0461] The present invention provides a method for enhancing root systems and / or enhancing the development of crop plants and / or enhancing the vigor of crop plants and / or improving the potential yield of plants comprising applying an effective amount of any of the mixtures or compositions disclosed herein to one or more plants, to the locus thereof or to propagation material thereof.
[0462] The present invention provides a method for enhancing plant development comprising applying an effective amount of any of the mixtures or compositions disclosed herein to one or more plants, to the locus thereof or to propagation material thereof so as to thereby enhance plant development.
[0463] The present invention provides a method for intensifying the root system comprising applying a Petition 870250102105, dated 07 / 11 / 2025, pp. 164 / 195 143 / 156 effective quantity of any of the mixtures or compositions disclosed herein to one or more plants, to the locus thereof or to propagation material thereof in such a way as to intensify the root system.
[0464] The present invention provides a method for enhancing plant vigor comprising applying an effective amount of any of the mixtures or compositions disclosed herein to one or more plants, to the locus thereof or to propagation material thereof so as to thereby enhance plant vigor.
[0465] The present invention provides a method for improving the potential yield of plants comprising applying an effective amount of any of the mixtures or compositions disclosed herein to one or more plants, to the locus thereof or to propagation material thereof so as to thereby improve the potential yield of the plants.
[0466] The present invention provides a method for regulating plant growth comprising applying an effective amount of any of the mixtures or compositions disclosed herein to one or more plants, to the locus thereof or to propagation material thereof so as to thereby regulate plant growth.
[0467] The present invention provides a method for controlling insects by contacting the insect or its food supply, habitat, breeding areas or locus with an effective amount of any of the mixtures or compositions disclosed herein so as to control the insects in this manner. Petition 870250102105, dated 07 / 11 / 2025, pages 165 / 195 144 / 156
[0468] The present invention provides a method of protecting plants from insect attack or infestation comprising contacting the plant, or the soil or water in which the plant is growing, with an effective amount of any of the mixtures or compositions disclosed herein so as to thereby protect the plants from insect attack or infestation.
[0469] This present invention also provides a method for enhancing the inactivation and / or prolonged control activity comprising contacting the plant, or the soil or water in which the plant is growing, with an effective amount of the mixture of Tau-fluvalinate and one or more active compounds II, as mentioned above, or a combination thereof, so as to thereby enhance the inactivation and / or prolonged control activity.
[0470] In one embodiment, this invention provides a method for controlling the insect comprising contacting the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the combination mixture of Tau-fluvalinate and one or more active compounds II, as mentioned above or the composition thereof, thereby controlling said insect.
[0471] In one embodiment, this invention provides a method for controlling the insect comprising contacting the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the combination mixture of Tau-fluvalinate and one or more active compounds II, as mentioned above or the composition thereof, wherein the insect is selected from a group comprising Spidermites, Halotydeus spp., Tetranychus Petition 870250102105, dated 07 / 11 / 2025, pages 166 / 195 145 / 156 urticae, Spodoptera littoralis, Spodoptera spp., Helicoverpa spp., Aphis spp., Myzus spp., Bemisia tabaci, Trialurodes vaporariorum, Tuta absoluta, Halyomorpha halys, Drosophila spp., Frankliniella spp., Aphis gossypii, Tetranichus spp., Lygus spp., Bactrocera dorsalis, B. tryoni, Ceratitis spp., Ceratitis capitata, Bactericera cockerelli, Nysius spp., Nilaparvata lugens, Ectomyelois ceratoniae, Amyelosis transitella, C. auricilius, Chilo spp., Cnaphalocerus medinalis, Cydia pomonella, S. innotata, Scirpophaga incertulas, Eriococcus spp., Ulonemia spp., Heliothrips haemorrhaidalis, Selenothrips spp. and Chaetanaphothrips spp. .
[0472] In one embodiment, this invention provides control of the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the combination mixture of Tau fluvalinate and the crop protection chemical as defined above, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0473] In another embodiment, this invention provides control of the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and a competitive modulator of the nicotinic acetylcholine receptor (nAChR), in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0474] In a specific embodiment, this invention provides control of the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture. Petition 870250102105, dated 07 / 11 / 2025, pages 167 / 195 146 / 156 of Tau fluvalinate and Flupirimine, in a weight ratio of 1:100 to 100:1, in order to control the aforementioned insect.
[0475] In one embodiment, this invention provides control of the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and a meta-diamide insecticide, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0476] In a specific embodiment, this invention provides control of the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and Isocycloseram, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0477] In one embodiment, this invention provides control of the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and a plant extract, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0478] In one embodiment, this invention provides control of the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and Garlic Extract, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner. Petition 870250102105, dated 07 / 11 / 2025, pages 168 / 195 147 / 156
[0479] In one embodiment, this invention provides control of the insect Spodoptera littoralis by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the combination mixture of Tau fluvalinate and the crop protection chemical as defined above, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0480] In one embodiment, this invention provides control of the insect Spodoptera littoralis by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and a competitive modulator of the nicotinic acetylcholine receptor (nAChR), in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0481] In a specific embodiment, this invention provides control of the insect Spodoptera littoralis by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and Flupirimine, in a weight ratio of 1:100 to 100:1, so as to control said insect in this way.
[0482] In one embodiment, this invention provides control of the insect Spodoptera littoralis by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and an ecdysone receptor agonist, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner. Petition 870250102105, dated 07 / 11 / 2025, pp. 169 / 195 148 / 156
[0483] In a specific embodiment, this invention provides control of the insect Spodoptera littoralis by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and Methoxyfenozide, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0484] In one embodiment, this invention provides control of the insect Spodoptera littoralis by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and a meta-diamide insecticide, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0485] In a specific embodiment, this invention provides control of the insect Spodoptera littoralis by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and Isocycloseram, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
[0486] The following representative examples illustrate the practice of the present invention in some of its embodiments but should not be interpreted as limiting the scope of the invention. Other embodiments will be apparent to a person skilled in the art from consideration of the descriptive report and the examples. It is intended that the descriptive report, including the examples, be considered illustrative only without limiting the scope and coverage of the invention. Petition 870250102105, dated 07 / 11 / 2025, pp. 170 / 195 149 / 156
[0487] In some embodiments, the blend or synergistic blend comprises one or more additional active ingredients. In some embodiments, the blend or synergistic blend comprises one or more additional inactive ingredients.
[0488] Although the present disclosure of the invention may be susceptible to various modifications and alternative forms, specific embodiments have been described by way of example in detail herein. However, it should be understood that the present disclosure is not intended to be limited to the particular forms disclosed. Rather, the present disclosure is intended to cover all modifications, equivalents and alternatives falling within the scope of the present disclosure as defined by the following claims and their legal equivalents. Representative examples
[0489] Experiments may be carried out to determine the synergistic effect of the mixture combination comprising a mixture of i) Tau-fluvalinate and ii) a crop protection chemical compound such as Flupirimine, Isocycloseram, Methoxyfenozide, Garlic extract, Gamma-cyhalothrin, Alpha-cypermethrin, Flupiradifurone, Chlorfenapyr, Tetrachlorantraniliprole, Bensultap, Phenazaquine, Fluxamethamide, Phenoxycarb, Milbemectin, Metaflumizone, Diflubenzurone, Spidoxamate, Granulovirus, Nucleopolyhedrosis virus, Flomethoquine, Ibuprofen, Chromafenozide, Acequinocil, Clitoria ternatea, GSomega peptide / kappa HXTX-Hv1a, Acinonapyr, N-octyl bicycloheptene dicarboximide (MGK-264), Pidiflumethophene, Cycloxapride, Cyflumethophene, Ciproflanilide Petition 870250102105, dated 07 / 11 / 2025, pages 171 / 195 150 / 156 Dichloromezothiaz, Dimpropyridaz, Fluazaindolizine, Flufiprol, Fluhexaphone, Lotilaner, Indazapyroxamet, paraffin oils, Thymol, Diatomaceous earth and Polydimethylsiloxane.
[0490] A mixture combination was prepared by thoroughly mixing Tau-fluvalinate (% by weight) with a crop protection chemical compound such as Flupirimine, Isocycloseram, Methoxyfenozide and Garlic extract (% by weight).
[0491] Different concentrations of each of the active ingredients can be applied to different insect species. Control percentages are determined some time after treatment.
[0492] A synergistic effect exists whenever the action of a combination of active ingredients is greater than the sum of the action of each ingredient individually. Therefore, a synergistic combination is a combination of active ingredients having an action that is greater than the sum of the action of each active ingredient individually, and a synergistically effective amount is an effective amount of a synergistic combination.
[0493] The Colby method is used to determine if there is synergy for a combination of active ingredients. According to Colby, the expected action (E) of the active ingredients A+B is: ABE = A+B-(iõÒ> where E = expected efficacy, A and B = the efficacy of two active ingredients A and B at a given dose.
[0494] When the observed percentage of control (O) for the combination is greater than the expected percentage (E), a synergistic effect exists. The synergism ratio (R) is Petition 870250102105, dated 07 / 11 / 2025, pages 172 / 195 151 / 156 is calculated as the ratio between the expected values and the observed values. If the synergism ratio (R) between the observed and the expected is >1, then synergy is exhibited; if R = 1, then the effect is additive; and if R < 1, then the mixture is antagonistic.
[0495] For a more detailed description of Colby's formula, see Colby, SR “Calculating synergistic and antagonistic responses of herbicide combination”, Weeds, Vol. 15, pages 20-22; 1967; see also Limpel et al., Proc. NEWCC 16: 48-53 (1962).
[0496] Insecticidal compounds A (Tau fluvalinate) and B (mixing partner) are formulated as equivalent compositions to eliminate the effects of different formulation inerts on biological activity. The efficacy of the insecticidal compositions is evaluated with reference to a scale of 0% to 100% compared to untreated control plots. 0 means no damage and 100 means complete destruction of harmful pests.
[0497] The experiments were conducted by application by synthesis / extraction or commercially available formulations of Tau fluvalinate and other mixing partners, alone or with their compositions mixed in a tank with the same weight ratio. The compositions were diluted with water or other suitable solvents to the indicated concentration of the active compounds.
[0498] Each formulation with active ingredient is diluted with water or other suitable solvent(s) to the ppm (parts per million) level and biological efficacy tests on pests are conducted. Petition 870250102105, dated 07 / 11 / 2025, pages 173 / 195 152 / 156
[0499] The following experiments were conducted with various mixtures of Tau fluvalinate on different types of pests, the results of which are summarized in the tables below: Table 1: Tau-Fluvalinate + Flupirimine THE) Synergistic Activity of Tau-Fluvalinate + Flupirimine against B. tabaci, 3 days after nymph exposure. Active Ingredient | Rate (ppm) | % observed control (0) | % expected control (E) | Synergism Ratio (R) | Tau-Fluvalinate | 0.1 | 14 | — Flupirimine | 1.1 EC | 0.1 | 24.4 | — Tau-Fluvalinate + Flupirimine | 1.1 EC | 0.1 + 0.1 | 52.9 | 34.98 | 1.512 B) Synergistic Activity of Tau-Fluvalinate + Flupirimin against S. littoralis, 2 days after larval exposure Active Ingredient Rate (ppm) % observed control (0) % expected control (E) Synergism Ratio (R) Tau-Fluvalinate 10 43 — Flupirimin 1 0 — Petition 870250102105, dated 07 / 11 / 2025, pages 174 / 195 153 / 156 Flupyrimine 10 0 — Flupyrimine 100 18 — Tau- Fluvalinate + Flupyrimine 10 + 1 90 43 2,093 Tau- Fluvalinate + Flupyrimine 10 + 10 75 43 1, 744 Tau- Fluvalinate + Flupyrimine 10+100 90 53, 26 1, 690 Table 2: Tau-Fluvalinate + Garlic Extract Synergistic Activity of Tau-Fluvalinate + Garlic Extract against B. tabaci, 3 days after nymph exposure. Active Ingredient | Rate (ppm) | % observed control (0) | % expected control (E) | Synergism Ratio (R) | Tau-Fluvalinate 20 | 28.1 | Garlic Extract 20 | 19.8 | Garlic Extract 40 | 33.8 | Tau-Fluvalinate + Garlic Extract 20+20 | 48.6 | 42.34 | 1.148 Petition 870250102105, dated 07 / 11 / 2025, pages 175 / 195 154 / 156 Tau-Fluvalinate + Garlic Extract 20 + 40 54.8 52.4 1.046 Table 3: Tau-Fluvalinate+ Methoxyfenozide Synergistic Activity of Tau-Fluvalinate + Methoxyfenozide against S. littoralis, 3 days after larval exposure. Active Ingredient | Rate (ppm) | % observed control (0) | % expected control (E) | Synergism Ratio (R) | Tau-Fluvalinate 0.2 | 2.5 | Tau-Fluvalinate 2 | 22.5 | Tau-Fluvalinate 10 | 67.5 | Methoxyfenozide 1 | 52.5 | Methoxyfenozide 2 | 70 | Tau-Fluvalinate + Methoxyfenozide 0.2+2 | 90 | 70.75 | 1.27 | Tau-Fluvalinate + Methoxyfenozide 2+2 | 82.5 | 76.75 | 1.07 | Tau-Fluvalinate + Methoxyfenozide 10+1 | 85 | 84.56 1,005 Petition 870250102105, dated 07 / 11 / 2025, pages 176 / 195 155 / 156 Table 4: Tau-Fluvalinate + Isocycloseram THE) Synergistic Activity against B. tabaci, 3 days after nymph exposure. Active Ingredient | Rate (ppm) | % observed control (O) | % expected control (E) | Synergism Ratio (R) | Tau-Fluvalinate | 0.2 | 10.4 | Isocycloseram | 0.2 | 25.5 | Tau-Fluvalinate + Isocycloseram | 0.2 + 0.2 | 46.3 | 33.25 | 1.392 B) Synergistic Activity of Tau-Fluvalinate + Isocycloseram against S. littoralis, 2 days after larval exposure. Active Ingredient | Rate (ppm) | % observed control (O) | % expected control (E) | Synergism Ratio (R) | Tau-Fluvalinate 8 | 45 | Tau-Fluvalinate 16 | 62.5 | Isocycloseram 8 | 12.2 | Tau-Fluvalinate + Isocycloseram 8 + 8 | 85 | 51.71 | 1.64 | Tau-Fluvalinate + Isocycloseram 16 + 8 | 95 | 70.94 | 1.34 |
[0500] Green cells represent a very high synergistic effect (above 120%), light green cells Petition 870250102105, dated 07 / 11 / 2025, pages 177 / 195 156 / 156 represents more than 100% but less than 120% synergism, meaning not antagonism but below pronounced synergism.
[0501] Although the present disclosure of the invention may be susceptible to various modifications and alternative forms, specific embodiments have been described by way of example in detail herein. However, it should be understood that the present disclosure is not intended to be limited to the particular forms disclosed. Rather, the present disclosure is intended to cover all modifications, equivalents and alternatives falling within the scope of the present disclosure as defined by the following claims and their legal equivalents. Petition 870250102105, dated 07 / 11 / 2025, pp. 178 / 195
Claims
1 / 16 CLAIMS 1. Combination of a mixture of active compounds, characterized in that it comprises: i) Tau-fluvalinate and ii) at least one crop protection chemical compound II selected from a group comprising (1) to (38): (1) a synthetic pyrethroid selected from a group consisting of Gamma-cyhalothrin, Alpha-cypermethrin, Etofenprox and Tefluthrin, (2) a competitive modulator of the nicotinic acetylcholine receptor (nAChR) selected from a group comprising Flupiradifurone, Flupirimine and Triflumezopirim, (3) an oxidative phosphorylation uncoupler via proton gradient disruption comprising Chlorfenapyr and Brochlorfenapyr, (4) a ryanodine receptor modulator selected from a group comprising Tetrachlorantraniliprole and Thiotraniliprole, (5) a blocker from the nicotinic acetylcholine receptor channel selected from a group comprising Bensultap, Cartap hydrochloride, Thiocyclam and Tissultapesodium,(6) A mitochondrial complex electron transport inhibitor (METI) selected from a group comprising phenazaquine, pyridaben, pyrimidinifene, tebufenpyrad and cyepyrafene, (7) a meta-diamide insecticide selected from a group comprising fluxamethamide and isocycloseram, (8) a broad-spectrum insect growth regulator selected from a group comprising phenoxicarb, Petition 870250102105, 07 / 11 / 2025, p. 179 / 195 2 / 16 (9) an allosteric modulator of the glutamate-gated chloride channel (GluCl) selected from a group comprising Milbemectin and Lepimectin, (10) a voltage-dependent sodium channel blocker selected from a group comprising Metaflumizone, (11) a chitin biosynthesis inhibitor affecting CHS1, selected from a group comprising Diflubenzurone, Flufenoxurone, Lufenurone, Teflubenzurone and Chlorfluazurone, (12) an acetyl CoA carboxylase inhibitor selected from a group comprising Spidoxamate,Spirodiclofen and Spiromesifene, (13) an entomopathogenic fungal agent comprising Beauveria spp., Metarhizium spp. and Paecilomyces spp., (14) A Baculovirus comprising: - Granuloviruses such as GV of Cydia pomonella, GV of Thaumatotibia leucotreta, - Nucleopolyhedrosis viruses such as MNPV of Anticarsia gemmatalis and MNPV of Helicoverpa armigera, (15) An inhibitor of mitochondrial complex III electron transport - Qi site comprising Flomethoquine, (16) an inhibitor of chitin biosynthesis (type 1) comprising Buprofezin, (17) an ecdysone receptor agonist comprising Cromafenozide, Halofenozide, Methoxyfenozide and Tebufenozide, (18) An inhibitor of mitochondrial complex III electron transport (QO site) comprising Acequinocil, Fluacripyrim and Hydramethylnon, (19) A cyclotide insecticide and repellent comprising Clitoria ternatea, Petition 870250102105, dated 07 / 11 / 2025,pg. 180 / 195 3 / 16 (20) an allosteric modulator of the nicotinic acetylcholine receptor (nAChR) (site II) comprising peptide GSomega / kappa HXTX-Hv1a, (21) a modulator of the calcium-activated potassium channel (KCa2) comprising acinonapyr, (22) a synergistic insecticidal agent comprising N-octyl bicycloheptene dicarboximide (MGK-264), Piprotal, Propyl isosome, Sesamex, Sesamolin and Sulfoxide, (23) a fungicide selected from a group comprising Pidiflumethophene, Fluazinam, Fluxapyroxad, Difenoconazole, Tebuconazole, Fludioxonil, Azoxystrobin and Mancozeb, (24) a neonicotinoid insecticide selected from a group comprising Cycloxapride, Guadipyr and Imidaclotiz, (25) an acaricide selected from a group comprising cyflumethophene and sila-cyflumethophene, (26) a diamide insecticide selected from a group comprising cyproflanilide, (27) a mesoionic insecticide selected from a group comprising dichloromezotiaz and phenmezodithiaz,(28) a pyrazole carboxamide insecticide selected from a group comprising Dimpropiridaz, Ticlopyrazoflor, Fluchlordiniliprole, (29) a sulfonamide nematicide selected from a group comprising Fluazaindolizine, (30) a phenylpyrazole insecticide selected from a group comprising Flufiprol, Nicofluprol and Piriprol, (31) a fluorine-containing insecticide selected from a group comprising Fluhexaphone, Bistriflurone and Trifluenfuronate, Petition 870250102105, dated 07 / 11 / 2025, page. 181 / 195 4 / 16 (32) an isoxazoline parasiticide selected from a group comprising lotilaner, (33) an indazole insecticide selected from a group comprising indazapyroxamet, (34) one or more mineral oils including paraffinic oils, (35) a plant extract selected from a group comprising garlic extract, bitterberry extract, tea tree oil and clove oil,(36) a monoterpene alcohol extracted from essential oils selected from a group comprising Citronella oil, Rose oil and Palmarosa oil, wherein the monoterpene alcohol is selected from the group comprising Geraniol, (37) a repellent selected from a group comprising Thymol and Citronella; and (38) one or more agrochemically acceptable additives selected from a group comprising Diatomaceous earth, Amorphous silica, Hydroxypropylmethylcellulose, Kaolin (calcined), Polydimethylsiloxane and Potassium salts of fatty acids.
2. Mixture combination according to claim 1, characterized in that the weight ratio between Tau fluvalinate and one or more active compounds II, as defined in claim 1, is from 1:100 to 100:
1.
3. Mixture combination according to claim 1, characterized in that Tau fluvalinate and at least one crop protection chemical compound II, as defined in claim 1,are applied together or in succession. Petition 870250102105, dated 07 / 11 / 2025, pp. 182 / 195 5 / 16 4. Mixture combination, according to any one of claims 1, 2 or 3, characterized in that the mixture is selected from the group comprising: 1) Tau-fluvalinate and Gamma-cyhalothrin, 2) Tau-fluvalinate and Alpha-cypermethrin, 3) Tau-fluvalinate and Etofenprox, 4) Tau-fluvalinate and Tefluthrin, 5) Tau-fluvalinate and Flupyradifurone, 6) Tau-fluvalinate and Flupyrimine, 7) Tau-fluvalinate and Triflumezopyrim, 8) Tau-fluvalinate and Chlorfenapyr, 9) Tau-fluvalinate and Brochlorfenapyr, 10) Tau-fluvalinate and Tetrachlorantraniliprol, 11) Tau-fluvalinate and Tiotraniliprol, 12) Tau-fluvalinate and Bensultape, 13) Tau-fluvalinate and Cartape Hydrochloride, 14) Tau-fluvalinate and Thiocyclam, 15) Tau-fluvalinate and Tissultap sodium, 16) Tau-fluvalinate and Phenazaquine, 17) Tau-fluvalinate and Pyridabene, 18) Tau-fluvalinate and Pyrimidiphene, 19) Tau-fluvalinate and Tebufenpyrad, 20) Tau-fluvalinate and Cietpirafen 21) Tau-fluvalinate and Fluxametamide 22) Tau-fluvalinate and Isocycloseram 23) Tau-fluvalinate and Fenoxycarb 24) Tau-fluvalinate and Milbemectin 25) Tau-fluvalinate and Lepimectin 26) Tau-fluvalinate and Metaflumizone 27) Tau-fluvalinate and Diflubenzuron Petition 870250102105, dated 07 / 11 / 2025, page 183 / 195 6 / 16 and Flufenoxuron and Lufenuron and Teflubenzuron and Chlorfluazuron 28) Tau-fluvalinate 29) Tau-fluvalinate 30) Tau-fluvalinate 31) Tau-fluvalinate 32) Tau-fluvalinate 33) Tau-fluvalinate 34) Tau-fluvalinate 35) Tau-fluvalinate 36) Tau-fluvalinate 37) Tau-fluvalinate 38) Tau-fluvalinate 39) Tau-fluvalinate 40) Tau-fluvalinate 41) Tau-fluvalinate 42) Tau-fluvalinate 43) Tau-fluvalinate 44) Tau-fluvalinate 45) Tau-fluvalinate 46) Tau-fluvalinate 47) Tau-fluvalinate 48) Tau-fluvalinate 49) Tau-fluvalinate 50) Tau-fluvalinate 51) Tau-fluvalinate 52) Tau-fluvalinate 53) Tau-fluvalinate 54) Tau-fluvalinate 55) Tau-fluvalinate octila (MGK-264) 56) Tau-fluvalinate and Spidoxamate and Spirodiclofen and Spiromesifen and Beauveria spp. and Metarhizium spp. and Paecilomyces spp. and GV of Cydia pomonella and GV of Thaumatotibia leucotreta and GV of Thaumatotibia leucotreta and MNPV of Anticarsia gemmatalis and NPV of Helicoverpa armigera and Flomethoquine and Buprofezin and Chromafenozide and Halofenozide and Methoxyfenozide and Tebufenozide and Acequinocil and Fluacripyrim and Hydramethylnon and Clitoria ternatea and GS-omega / kappa HXTX-Hv1a peptide and Acinonapyr and Ne Piprotal bicycloheptene dicarboximide Petition 870250102105, dated 07 / 11 / 2025, page. 184 / 195 7 / 16 57) Tau-fluvalinate and 58) Tau-fluvalinate and 59) Tau-fluvalinate and 60) Tau-fluvalinate and 61) Tau-fluvalinate and 62) Tau-fluvalinate and 63) Tau-fluvalinate and 64) Tau-fluvalinate and 65) Tau-fluvalinate and 66) Tau-fluvalinate and 67) Tau-fluvalinate and 68) Tau-fluvalinate and 69) Tau-fluvalinate 70) Tau-fluvalinate 71) Tau-fluvalinate 72) Tau-fluvalinate 73) Tau-fluvalinate 74) Tau-fluvalinate 75) Tau-fluvalinate 76) Tau-fluvalinate 77) Tau-fluvalinate 78) Tau-fluvalinate 79) Tau-fluvalinate 80) Tau-fluvalinate 81) Tau-fluvalinate 82) Tau-fluvalinate 83) Tau-fluvalinate 84) Tau-fluvalinate 85) Tau-fluvalinate 86) Tau-fluvalinate and Propyl Isome Sesamex Sesamolin Sulfoxide Pidiflumethophen Fluazinam Fluxapyroxad Difenoconazole Tebuconazole Fludioxonil Azoxystrobin Mancozeb Cycloxapride Guadipir Imidaclotiz Cyflumethophen Sila-Ciflumethophen Ciproflanilide Dichlormezothiaz Fenmezothiaz Dimpropiridaz Ticlopyrazoflor Fluchlordiliprol Fluazaindolizine Flufiprol Nicofluprol Piriprol Fluhexaphone Bistriflurone Trifluenfuronate Petition 870250102105, dated 07 / 11 / 2025, pp. 185 / 195 8 / 16 87) Tau-fluvalinate and Lotilaner 88) Tau-fluvalinate and Indazapiroxamet 89) Tau-fluvalinate and mineral oil, including paraffinic oils 90) Tau-fluvalinate and Garlic Extract 91) Tau-fluvalinate and bitterberry extract 92) Tau-fluvalinate and Tea Tree Oil 93) Tau-fluvalinate and clove oil 94) Tau-fluvalinate and Citronella Oil 95) Tau-fluvalinate and Rose Oil 96) Tau-fluvalinate and Palmarosa oil 97) Tau-fluvalinate and Geraniol 98) Tau-fluvalinate and Thymol 99) Tau-fluvalinate and one or more agrochemically acceptable additives selected from a group comprising Diatomaceous earth, Amorphous silica, Hydroxypropylmethylcellulose, Kaolin (calcined), Polydimethylsiloxane and Potassium salts of fatty acids.
5. Mixture combination according to any one of claims 1, 2, 3 or 4, characterized in that the mixture exhibits synergistic effects.
6. Mixture combination according to any one of claims 1, 2, 3, 4 or 5, characterized in that the weight ratio of Tau fluvalinate and the Nicotinic Acetylcholine Receptor Competitive Modulator (nAChR) is 1:50 to 50:
1.
7. Mixture combination according to claim 6, characterized in that the weight ratio of Tau fluvalinate and Flupirimine is 1:50 to 50:
1. Petition 870250102105, dated 07 / 11 / 2025, pp. 186 / 195 9 / 16 8.A mixture combination according to claim 7, characterized in that the weight ratio of Tau fluvalinate and Flupirimine is 1:10 to 10:
1.
9. A mixture combination according to any one of claims 1, 2, 3, 4 or 5, characterized in that the weight ratio of Tau fluvalinate and a meta-diamide insecticide is 1:50 to 50:
1.
10. A mixture combination according to claim 9, characterized in that the weight ratio of Tau fluvalinate and Isocycloseram is 1:50 to 50:
1.
11. A mixture combination according to claim 10, characterized in that the weight ratio of Tau fluvalinate and Isocycloseram is 1:1 to 5:
1.
12. Mixture combination, according to any one of claims 1, 2, 3, 4 or 5, characterized in that the weight ratio of Tau fluvalinate and Ecdysone receptor is 1:50 to 50:
1. 13.Mixture combination according to claim 12, characterized in that the weight ratio of Tau fluvalinate and Methoxyfenozide is 1:50 to 50:
1.
14. Mixture combination according to claim 13, characterized in that the weight ratio of Tau fluvalinate and Methoxyfenozide is 1:1 to 5:
1.
15. Mixture combination according to any one of claims 1, 2, 3, 4 or 5, characterized in that the weight ratio of Tau fluvalinate and plant extract is 1:50 to 50:
1.
16. Mixture combination according to claim 15, characterized in that the weight ratio of Tau fluvalinate and garlic extract is 1:
1. Petition 870250102105, dated 07 / 11 / 2025, p. 187 / 195 10 / 16 17. Mixture combination, according to any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16, characterized in that the application rates of the mixture according to the invention are from 1 g / ha to 1000 g / ha. 18.Pesticide composition, characterized in that it comprises: (i) the mixture combination as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 or 17; and (ii) an agriculturally acceptable transport.
19. Pesticide composition according to claim 18, characterized in that it further comprises at least one surfactant, solid diluent, liquid diluent or a combination thereof.
20. A method for controlling insects, characterized in that it comprises contacting the insect or its food supply, habitat, breeding areas or locus with an effective amount of the mixture combination, as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 or 17, or of the composition, as defined in any one of claims 18 or 19, so as to control the insects in this way. 21.Método para controlar insetos, de accordo com a reivindicação 20, characterized by the hair fate de que os insects are selected from a group comprising Spidermites, Halotydeus spp., Tetranychus urticae, Spodoptera littoralis, Spodoptera spp., Helicoverpa spp., Aphis spp., Myzus spp., Bemisia tabaci, Trialurodes vaporariorum, Tuta absoluta, Halyomorpha halys, Drosophila spp., Frankliniella spp., Petition 870250102105, of 07 / 11 / 2025, p. 188 / 195 11 / 16 Aphis gossypii, Tetranichus spp., Lygus spp., Bactrocera dorsalis, B. tryoni, Ceratitis spp., Ceratitis capitata, Bactericera cockerelli, Nysius spp., Nilaparvata lugens, Ectomyelois ceratoniae, Amyelosis transitella, C. auricilius, Chilo spp., Cnaphalocerus medinalis, Cydia pomonella, S. innotata, Scirpophaga incertulas, Eriococcus spp., Ulonemia spp., Heliothrips haemorrhaidalis, Selenothrips spp. and Chaetanaphothrips spp.. 22.A method according to claim 21, characterized in that it is for controlling the insect Bemisia tabaci by contacting the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture combination, as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 or 17, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
23. Method according to claim 22, characterized in that it is for controlling the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and a competitive modulator of the nicotinic acetylcholine receptor (nAChR), as defined in claim 1, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner. 24.Method, according to claim 23, characterized in that it is for controlling the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of a mixture of Tau fluvalinate and Flupirimine, in a ratio by weight of 1:100 to 100:1, so as to control said insect in this way.
25. Method according to claim 22, characterized in that it is for controlling the insect Bemisia tabaci by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and a metadiamide insecticide, as defined in claim 1, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner. 26.A method according to claim 25, characterized in that it is for controlling the insect Bemisia tabaci by contacting the insect or its food supply, habitat, breeding areas or its locus with an effective amount of a mixture of Tau fluvalinate and Isocycloseram, in a weight ratio of 1:100 to 100:1, so as to control said insect in this way.
27. A method according to claim 22, characterized in that it is for controlling the insect Bemisia tabaci by contacting the insect or its food supply, habitat, breeding areas or its locus with an effective amount of a mixture of Tau fluvalinate and a plant extract, as defined in claim 1, in a weight ratio of 1:100 to 100:1, so as to control said insect in this way. 28.A method, according to claim 27, characterized in that it is for controlling the insect Bemisia tabaci by contacting the insect or its food supply, habitat, breeding areas or its locus with an effective amount of a mixture of Tau fluvalinate and plant extract, in a weight ratio of 1:100 to 100:1, so as to control said insect in this way.
29. Method according to claim 21, characterized in that it is for controlling the insect Spodoptera littoralis by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture combination, as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 or 17, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner. 30.A method according to claim 29, characterized in that it is for controlling the insect Spodoptera littoralis by contacting the insect or its food supply, habitat, breeding areas, or locus with an effective amount of a mixture of Tau fluvalinate and a competitive modulator of the nicotinic acetylcholine receptor (nAChR), as defined in claim 1, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner.
31. A method according to claim 30, characterized in that it is for controlling the insect Spodoptera littoralis by contacting the insect or its food supply, habitat, breeding areas, or locus with an effective amount of a mixture of Tau fluvalinate and Flupirimine, in a weight ratio of 1:100 to 100:1, so as to control said insect in this manner. 32.Method, according to claim 29, characterized in that it is for controlling the insect Spodoptera littoralis by contact of the insect or its feeding, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and an ecdysone receptor agonist, as defined in claim 1, in a weight ratio of 1:100 to 100:1, so as to control said insect in this way.
33. Method, according to claim 32, characterized in that it is for controlling the insect Spodoptera littoralis by contact of the insect or its food supply, habitat, breeding areas or its locus with an effective amount of a mixture of Tau fluvalinate and Methoxyfenozide, in a weight ratio of 1:100 to 100:1, so as to control said insect in this way. 34.A method according to claim 29, characterized in that it is for controlling the insect Spodoptera littoralis by contacting the insect or its food supply, habitat, breeding areas or its locus with an effective amount of the mixture of Tau fluvalinate and a meta-diamide insecticide, as defined in claim 1, in a weight ratio of 1:100 to 100:1, so as to control said insect in this way.
35. A method according to claim 34, characterized in that it is for controlling the insect Spodoptera littoralis by contacting the insect or its food supply, habitat, breeding areas or its locus with an effective amount of a mixture of Tau fluvalinate and Isocycloseram, in a weight ratio of 1:100 to 100:1, so as to control said insect in this way. 36.A method for protecting plants from insect attack or infestation, characterized in that it comprises contacting the plant, or the soil or water in which the plant is growing, Petition 870250102105, dated 07 / 11 / 2025, pp. 192 / 195 15 / 16 with an effective amount of the mixture, as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 or 17, or of the composition, as defined in any one of claims 18 or 19, so as to thereby protect the plants from insect attack or infestation. 37.A method for intensifying inactivation and / or prolonged control activity, characterized in that it comprises contacting the plant, or the soil or water in which the plant is growing, with an effective amount of the mixture, as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 or 17, or of the composition, as defined in any one of claims 18 or 19, so as to thereby intensify the inactivation and / or prolonged control activity.
38. A method for intensifying plant development, characterized in that it comprises applying to the plant, to a plant locus and / or plant propagation material an effective amount of the mixture, as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 or 17, or of the composition, as defined in any one of claims 18 or 19, so as to thereby intensify plant development. 39.A method for regulating plant growth, characterized in that it comprises applying to the plant, to a plant locus and / or plant propagation material an effective amount of the mixture, as defined in any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 or 17, or of the composition, as defined in any one of claims 18 or 19, so as to regulate plant growth.
